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ABSTRACT 
The research strategy is focused on the potential prevention and treatment of cognitive 
impairment by recommending the consumption of herbal-coffee beverages as early as possible 
in life. General methods applicable for the analysis and extraction that are suitable for the 
preparation of a range of herbal-coffee beverages have been found. The herb-bioactive 
compounds are effectively extracted simply by using a coffee machine or microwave heating.  
These herbal-coffee beverages may provide significant neuro-protection against dementia and 
Alzheiŵeƌ͛s disease, iŶĐludiŶg the deǀelopŵeŶt of the fiƌst eǆaŵples ĐoŶtaiŶiŶg giŶgeƌ, liquorice 
and ginseng in coffee brews. Caffeine, caffeic acid and Vitamin B1 combined with HEWL to 
strongly inhibit ThT fluorescence. A small study of the perception and sensory responses to the 
new beverages was undertaken.  
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1 
Introduction 
 
͞The ŵore iŵportaŶt reasoŶ is that the researĐh itself provides aŶ iŵportaŶt loŶg-run perspective on the 
issues that we face on a day-to-day ďasis.͟  
Ben Bernanke 
 
1.1 Project Background  
 
By 2050 it is estimated that the number of people over the age of 80 will triple globally and cognitive 
decline and dementia could become the greatest challenge of our times. According to the 2003 
World Health Estimates Report, dementia inflicts 11.2% elderly people (>60 years) more than stroke, 
cardiovascular disease and various cancers [1]. Dementia is a collection of different disorders that 
influence brain function such as progressive memory loss, judgment decline and other symptoms; 
Alzheiŵeƌ͛s disease (AD) is the most common type of memory disorder and contributes to between 
50% and 70% of all types of dementia [2]. From neuroimaging, AD advances in three stages: an early 
and preclinical stage with no symptoms; a middle stage of mild cognitive impairment (MCI); and a 
final stage of AD. [3] [Fig.1.1 (a)] The pathological process of AD can have a long development time 
even to 40-50 years (including the early and MCI periods) [4].  
 
MCI is defined as the clinical condition of memory between normal aging and AD; in other words, 
patients with MCI incur more memory loss problems than healthy people of a similar age, however 
they do not yet have the cognitive function issues and criteria for AD [5]. According to 
epidemiological studies, elderly people have been classified as the highest risk of population to 
suffer from AD [6]. For example, the many memory complaints elderly people have include, having 
trouble remembering friends names they meet often, having a greater probability to misplace things 
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yet have normal judgment and thinking skills. These people can suffer from MCI for extended 
periods of time. They are at high risk (approximately 80%) of accelerating to a dementia disorder 
such as AD (mostly in 6 years); however their dementia may be slowed even stabilised after 
satisfactory therapeutic and lifestyle interventions [7].  Therefore, aging associated memory 
impairment is a major risk factor for the general degradation of memory that can progress from MCI 
[8,9] symptoms to AD [10]. Although it is difficult to deteƌŵiŶe ǁhetheƌ a peƌsoŶ͛s ŵeŵoƌǇ loss 
reflects MCI symptoms. Aging is the highest risk factor that necessitates medical treatment for AD 
for which there is no known cure. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.1.1 (a) The AD development stages (left). (b) Neuroimaging from a healthy person (the left of 
picture b) aŶd a patieŶt ǁith Alzheiŵeƌ͛s disease ;ƌightͿ [RepƌoduĐed fƌoŵ ƌefeƌeŶĐes 3, 14] 
 
 MCI symptoms and dementia is most likely caused by amyloid fibrils neurodegeneration that affect 
brain cells to communicate neural information, resulting in memory loss and behaviour and feeling 
changes. Damage in the memory and judgement functional regions such as the temporal lobe and 
corpus callosum [Fig.1.1 (b)] is the cause of memory loss and one of the earliest symptoms of AD. 
Amyloid fibrils are aggregated by normally soluble amyloid protein and are found in a wide range of 
misfolded β-sheet amyloid protein resistant to neuro-degradation [11]. Research studies indicate the 
structure of fibrils are mainly composed of β-sheet structure in a characteristic cross-β ĐoŶfoƌŵatioŶ 
[12]. Therefore, aŵǇloid β peptides ;AβͿ aƌe the ŵaiŶ ĐoŵpoŶeŶts of the aŵǇloid plaƋues fouŶd iŶ 
the brains of Alzheimer patients where it is deposited abnormally in senile plaques containing both 
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AβϰϬ aŶd AβϰϮ. Aβ is produced from the amyloid precursor protein (APP) by the sequential cleavage 
ǀia β- and γ-secretases [13]. Currently there are no medications that can remove or affect the 
dissolution of toxic Aβ fƌoŵ ŶeuƌoŶs to iŵpƌoǀe ĐogŶitiǀe aďilitǇ.   
 
Symptomatic treatments have been widely applied for AD since the mid-1990s. There are two types 
of medications, cholinesterase inhibitors (Donepezil, Rivastigmine, Galantamine) and NMDA 
receptor antagonist (Memantine), that are approved by the USA Food and Drug Administration to 
relieve the cognitive symptoms (such as memory loss, confusion) of mild, moderate and severe AD 
[14] These drugs are based on sustaining the acetylcholine (ACh) neurotransmitter levels 
(galantamine and the physostigmine-derivative rivastigmine) [15] in AD patients with cognitive 
degeneration have cholinergic neurons deficits in due to a decline in the levels of ACh in the 
hippocampus, temporal and parietal neocortex.  ACh is hydrolytically destroyed by two 
cholinesterases, AChE and butyryl-cholinesterase (BuChE). As AD progresses, AChE activity can  
decrease by up to 67% of normal levels in the temporal lobe and hippocampus [16]. Thus, 
Cholinesterase inhibitors are commonly used for the treatment of symptoms of AD cognitive decline, 
but does not stop/prevent neuronal damage. NMDA glutamate receptors are composed of abundant 
glutamate-gated cation channels with high calcium permeability, which are distributed throughout 
the central nervous system (CNS). They have important roles in the process that learning, memory, 
and neuroplasticity. Some neurological disorders including cognitive disorders are caused by 
receptor over activation (excitotoxicity) and subsequent neurodegeneration [17,18]. Many AD 
patient͛s memory loss and cognitive loss is due to prolonged Ca2+ excess and results in loss of 
synaptic function, followed by synaptotoxicity and ultimately cell death [19]. It is known that NMDA 
receptor inhibition and overactivation, leads to impairment of neuronal plasticity (learning) or cell 
death, and dysfunctional cognition [20]. Memantine is a low affinity, voltage-dependent and 
noncompetitive NMDA receptor antagonist, which has a higher affinity for Mg2+ and blocks Ca2+ 
influx. It has fast off-rate kinetics in the receptor channel, and so is only of benefit for dysfunctional  
synapses found in AD patients without affecting the physiological stimuli of the NMDA receptor [21]. 
Many AD patients have been recorded to have personality changes, behaviour and sleep difficulties 
even at the early stage. For example, the major behaviour alteration was apathy (72%), agitation 
(60%) and anxiety (48%), which significantly correlates to the cognitive deterioration caused by 
neuron cell damage in the brain [22]. Additionally, some medications may worsen these symptoms. 
Therefore, atypical antipsychotics such as risperidone, quetiapine, olanzapine, aripiprazole were 
utilized to treat the symptoms of short-term severe aggression in AD. However, these drugs have 
limited cognitive benefits, particularly risperidone that poses a significant risk for cerebrovascular 
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events [23, 24]. Currently, all antidepressants such as citalopram, sertraline are not licenced for AD 
treatment.  
 
In summary, many researchers acknowledge that current Alzheiŵeƌ͛s drugs cannot cure AD. These 
drugs and non-drug clinical conditions may ameliorate cognitive and behavioural symptoms for 
improving the quality of life for some patients with AD.  
 
A better strategy is to prevent AD onset or delay aging through the reduction of dementia risk 
factors; as the medications used to treat mild cognitive or dementia do not reverse the formation of 
͚ŶeuƌofiďƌillaƌǇ taŶgles͛.   There are seven risk factors that have been associated with one in three 
Alzheimer's disease cases. These include diabetes, midlife hypertension, midlife obesity, physical 
inactivity, smoking, depression, or low educational attainment [25,26]. These risk factors could 
promote AD with aging. The current lifestyle interventions preventing AD include better diets, brain 
games (Sudoku puzzles) and regular exercise. For example, research suggests that daily intake of fish 
with docosahexaenoic acid (DHA), and omega-3 fatty acid decreases the risk for AD [27]. Neurons 
and synapses are composed of long chain unsaturated fatty acids similar to omega-3; also lowering 
the dementia risk factors is related to the protection against cardiovascular disease [28].  
 
Scientific research demonstrates that strategies such as exercise and diet, significantly delay or 
prevent aging cognitive decline or memory loss, many of which are based on small group and short-
term studies. Obviously the dietary nutrition brain benefits are variable and it is common for people 
to take different kinds of foods containing vitamins, antioxidants and their effects are difficult to 
quantify. There is room for improvement, especially in generating personalised treatments, however 
the greatest advantage of dietary modifications is that they generally do not raise human safety 
issues.  
 
The health claims of traditional herbal remedies, their effectiveness and safe use are growing 
rapidly. Functional foods are also popular for consumers who are seeking specific health effects to 
promote physical fitness. Recent research found that many herbal compounds can affect the mind, 
mood, cognitive function or health. For example, ginseng has been reported to improve short-term 
memory performance when consumed as a dietary supplement.  S. lavandulaefolia Vahl. (Spanish 
sage) essential oil composition iŶĐludes α-pinene (4%-ϳ%Ϳ, β-pinene (5%-12%), 1,8-cineole (15%-
30%) and camphor (20%-30%, and it has been reported to improve accuracy for cognitive mental 
status examination after 6 week of use [29]. Certain herbs may be potentially important sources of 
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drug candidates against the onset of AD. For example, Zingiber officinale (ginger), Ginkgo biloba 
(ginkgo), Cinnamum cassia (Chinese cinnamon) extracts effectively protect primary neuronal cells 
agaiŶst Aβϭ-42 insult [30]. Huperzine A, originally isolated from Huperzia serrata, a type of moss 
used in traditional Indian and Chinese medicine and its derivative, ZT-1, is being developed as a new 
anti-AD drug for AD treatment. Yokukansan is composed of 7 herbs and is a useful formulation for 
the effective treatment of dementia symptoms in 106 patients diagnosed with AD that was safe to 
use [31].  
 
The production of a functional beverage using safety tractional herbs and to encourage its long term 
consumption would provide a sound strategy for neuroprotection against dementia and be of 
general benefits for society. Firstly, these herbal effective compounds can be extracted into water 
via a convenient procedure; moreover, these ingredients can be analytically measured the amount 
consumed can be quality controlled, allowing the opportunity to monitor/measure the benefits over 
several years; the last but not the least factor is the functional beverage can be modified according 
to personal sensory perceptions and blended into daily consumption similar to coffee or tea intake.      
 
1.2       Natural compound extraction methods and quality control 
 
 In order to quantify the herbal benefits for human health, the first important step is herb 
constituent extraction, separation, identification and quantitation/concentration of the herbal 
ingredients, as the bioactive compound concentration are product quality-related and also to herbal 
efficiency. These herbal bioactive substances can be classified into families of compounds including 
essential oils, alkaloids, steroids, saponins. Various classes of compounds have known methods for 
extraction for optimal pharmaceutical application [32]. For example, some bioactives found in plants 
are water soluble whilst others are hydrophobic/insoluble. Modern and traditional extraction and 
analysis techniques play an important role in food industry [33,34]. These techniques include 
decoction, percolation, Soxhlet extraction, solid phase micro-extraction, and microwave-assisted 
extraction, that are available in the lab or in domestic use. Chromatographic techniques have proven 
to be the most powerful and effective technology available for herbal analysis [35]. 
 
1.2.1 Decoction extraction 
 
The usage of green extraction technology (also traditional extraction techniques) is able to protect 
the natural environment and minimizes harmful chemical affects on human and environmental 
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health. Traditional Chinese herbal teas and Turkish coffee are commonly prepared in this way. For 
decoction methods, the extractive yield is determined by time/temperature and the chemical nature 
of the herb. Botanic herbs such as stem and root from licorice, ginseng and ginger, are finely ground 
to enhance maximum herb extraction [36]. Water is biocompatible and an eco-friendly medium, 
which can be used to extract many bioactive constituents including alkaloids, flavonoids, saponins, 
vitamins and others [37].  The herbs to water ratio used ranges from 1:4 to 1:10. Depending on the 
consistency of the parts to be extracted, the decoction times of herbs generally decreases in the 
order: roots > stems > leaves and flowers, when boiled in water for 5 to 60 minutes [38,39]. During 
this time the evaporated water must be replaced. Essential oils are isolated by distillation of the 
volatile organic compounds.  
 
1.2.2  Percolation extraction  
 
 Percolation is an extraction process whereby the slow passage of a solvent through fine substrate 
particles extracts constituents that pass through the filter into the collector. A coffee percolator is a 
good example of the percolation process, which was invented by Hanson Goodrich in 1889 [40]. 
Water is heated in the percolator chamber, passes through the vertical tube as steam-powered 
vacuum and is sprayed over the coffee grounds (that is continuously recycled through the grounds 
until complete) [Fig. 1.2(a)]. Extracted coffee was filtered into the bottom chamber. Percolation is a 
short and efficient extraction extraction procedure that can be applied to the extraction of certain 
herbs [41].  As required, the coffee or herbs should be ground into powder form with a coffee 
blender or commercial grinder. Some procedures require a preparatory step, to allow crude herbal 
particles to swell to their maximum size as dense dry fine particles may block the filter mesh after 
swelling and resist solvent flow, giving rise to inefficient extraction [42].   
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Fig.1.2. (a)Percolation extraction (left); (b)Conventional Soxhlet Extraction (middle); (c)Microwave-
assisted extraction (right) [Reproduced from references 50, 53] 
 
1.2.3 Soxhlet Extraction 
 
Soxhlet extraction was first described in 1879 by Franz von Soxhlet, who applied the apparatus to 
quantify fat in milk. It was then widely used for lipid extraction in agricultural chemistry [43]. The 
apparatus facilitates the separation of soluble compounds of interest from the insoluble solids with a 
solvent. The solvent reticulation enables continuous sample extraction from a few hours to days. 
Figure [Fig.1.2 (b)] illustrates the Soxhlet components of condenser, extractor and distillation flask. 
When the distillation flask is heated, the solvent vapour travels via the side-arm, liquefies on the 
condenser jacket and flow back through the thimble in the extraction chamber containing the 
crushed sample; the extractor chamber refills with the warm solvent slowly and extracts/dissolves 
the desired compounds from the crude material. The concentrated solvent returns to the distillation 
flask as the full chamber is emptied through the siphon arm. The fill-empty cycle is repeated until 
the extraction is deemed satisfactory [44]. The Soxhlet extractor has the advantage that it allows 
fresh recycled solvent to continuously extract the solid sample. The soluble compounds constantly 
dissolve in freshly condensed solvent and return to the extraction flask until all the soluble 
constituents are exhaustively extracted. The procedure operates automatically and is a gentle 
extraction process without agitation. The concentrated constituents are readily collected when 
completed [45].  This method was used for extraction of organic compounds from medicinal plant 
extracts including isoflavonoids from ginger [46], caffeine[47] from coffee and glycyrrhizin from 
liquorice [48]. Soxhlet extraction has been less used, as microwave-assisted extractions (MAE), 
supercritical fluid extraction (SFE), and pressurized solvent extraction (PSE) techniques are preferred. 
However, modified Soxhlet extractor systems such as high-pressure Soxhlet extraction, ultrasound-
assisted Soxhlet extraction, microwave-assisted Soxhlet extraction have been developed [50]. These 
new systems employ auxiliary apparatus to decrease leaching time and improve the extraction yield.   
 
1.2.4     Microwave-assisted extraction 
 
Microwave-assisted extraction (MAE) [Fig.2 (c)] is an efficient extraction technique, which applies 
microwave energy to heat the solvent/sample matrix containing plant tissue or herbs, allowing these 
natural compounds to be rapidly extracted from raw materials [51]. The technique was first used in 
22 | P a g e  
 
the laboratory in 1975 by Abu-Samra, who conducted the trace analysis of metals in biological 
samples and has become a very cost effective method [52]. The technique utilizes microwaves, 
electromagnetic energy waves are formed from electric and magnetic fields, with the spectral 
window between X-rays and infrared frequency from 0.3 to 300 GHz [53]. In general, the alternating 
current of electromagnetic energy interacts/aligns with the dipole moment of polar samples and/or 
polar solvents and this constant electric field-sample dipole rotation/realignment generates 
molecular friction converted to heat energy [54]. Only dielectric materials (such as porcelain 
(ceramic) glass and plastics) or solvents with permanent dipoles such as water are microwave active. 
A ceramic cup containing coffee or herbal tea can be heated in a domestic microwave. These herbal 
products contain minute traces of moisture that when heated by microwaves generate 
energy/pressure to break the plant cell walls so that many secondary metabolite bioactive 
compounds or aroma molecules can be dissolved in water [55]. MAE has many advantages, most 
significantly  it reduces the extraction time compared to traditional methods such as Soxhlet 
extraction, also increases extraction efficiency and yields.  There are several advanced MAE 
instruments commercially available including pressurized microwave-assisted extraction (PMAE) and 
solvent-free microwave-assisted extraction (SFMAE) technologies.  
 
1.2.5 SPME extraction 
 
'Headspace' refers to volatile extraction techniques of the gas above the sample of liquid or solid 
phase in a sealed chromatography vial, that started to be utilized in the late of 1950s. Headspace gas 
components are usually collected by a SPME fiber. Its advantage is simplicity of use, effectiveness 
and is a very clean method, which delivers volatile analytes into a gas chromatograph for analysis. 
 
Solid-phase microextraction (SPME) fibers were invented by Janusz Pawliszyn and patented at the 
University of Waterloo in Ontario, Canada [56]. At present Supelco Analytical (a division of Sigma-
Aldrich Co.) maintains  the distribution of the materials for SPME. Many disciplines are using this 
technique, including the analysis of food, aroma and pharmaceutical samples. When volatile sample 
constituents distribute into the gas phase and reach equilibrium between solid/liquid phase and gas 
phase, the volatiles are adsorbed (or absorbed) in the headspace over liquid/solid samples, then are 
dispensed to a GC column [49,57]. Thus, there are absorption and adsorption characteristic SPME 
types fiber coating. The most widely applied coating, polydimethylsiloxane (PDMS), consists of 
absorption via a high viscosity rubbery liquid. However, it appears as a solid and converts to liquid 
under desorption temperature. The other adsorption materials PDMS–DVB (divinylbenzene), 
23 | P a g e  
 
Carbowax–DVB and Carboxen are commercially available, that are mixed coatings via a porous 
extracting phase [58]. In this project, different kinds of fiber were used according to the molecular 
weight and polarity of the analytes to be studied. For instance 100 µM PDMS are used for the most 
volatile compounds with molecular weights from 60 to 275 [59]. 
 
The SPME fiber is assembled in a modified barrel, the manual SPME holder [Fig. 1.3(a)]. In the 
standby position, the fiber is situated in a protective septum-piercing needle. Prior to sampling, the 
liquid or solid samples are settled in the sealed GC vials, leaving enough headspace (more than the 
fiber exposed including the needle) over the sample; the fiber needle is forced into the vial and 
pushes the plunger retainiŶg sĐƌeǁ iŶ the ŵiddle of the ͞Z͟ slot. The SPME fiber, fused silica rod 
;tǇpiĐallǇ ϭ Đŵ loŶg aŶd Ϭ.ϭϭ μŵ i.d.) coated such as PDMS, is immersed the headspace contains the 
volatile compounds from the sample. After a time-interval (2-15 min), these compounds are 
subsequently absorbed and reach equilibrium.  The fiber is withdrawn after the needle is taken out 
of the sampling vial. The needle is then inserted into the GC injector, and the volatile analytes are 
immediately thermally desorbed in 1-2 minutes and enter the GC column. The fiber still needs to be 
kept in the needle when removed from the GC injector [60] [Fig. 1.3(b)]. The SPME fiber assembly is 
disposable and may be used for approximately 100 injections. 
 
 
  
 
Fig.1.3 (a) Manual Solid-phase micro-extraction (SPME) Holder (left) (b) SPME extraction process of 
absorption and release (right) [Reproduced from reference 60].  
 
Table 1 A brief summary of the experimental conditions for various methods of extraction 
for herbal products 
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 Decoction 
Extraction 
Percolation 
Extraction 
Soxhlet 
Extraction 
Microwave-assisted 
Extraction 
SPME 
Extraction 
Common Solvents 
used 
Mainly 
water  
Mainly water Methanol, 
ethanol, 
or mixture of 
alcohol and 
water 
 Water, ethanol, 
or mixture of 
alcohol and water 
Any solvent 
Temperature (°C) 100 90-100 Depending on 
solvent used 
Depending on 
solvent used 
Low/high 
Time required шϯϬ ŵiŶ чϮϬ ŵiŶ 3–18 hr чϭϬ ŵiŶ 2-30min 
Volume of solvent 
required (ml) 
Depending 
on herbal 
weight 
100-500 150–200 100-300 2-10 
Types of herbs Stem, root, 
seeds 
Ground: 
leaves, flower, 
seed, roots, 
stem 
Stem, root, 
seeds 
Any parts of herbs Herbal oil 
 
 
1.3     Natural compound quality control [QC] via chromatographic analysis 
 
Chromatography technology was first developed by Mikhail Tswett in 1901, separates the 
components in a mixture according to the different partitioning behaviours between a mobile phase 
and a stationary phase. The most common techniques are HPLC (High Performance Liquid 
Chromatography) and GC (Gas Chromatography). The stationary phase is packed into the column, 
through which the mobile phase (solvent or gas) continually passes. The sample is injected into the 
column.  The individual components elute from the column as determined by their partition 
coefficient in the mobile phase, and are collected and measured by the detector measuring UV 
adsorption (diode array detector, DAD), molecular weight (Mass spectrometry detector, MS) [61]. 
[Fig.1.4(a, b)] 
 
 
 
                                                                                          Compound B 
 
                                                                                          Compound A  
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Fig.1.4 (a) The components separation process. (left) (b)Individual retention time of the compound A 
and B elution from column. (right) [Reproduced from Agilent Technologies, Inc.] 
 
 Resolution(R) is utilized to describe the extent of the separation of compounds A and B. The 
resolution of two species (A and B), is defined as:  
R=
√𝑁4 ቀ𝛼−1𝛼 ቁ ቀ1+𝜅κ ቁ  where N expresses the number of theoretical plates, by lengthening the column leads to an 
increase in retention time, but in practice HPLC standard columns are fixed at about 15, 25 and 
ϯϬĐŵ; α, the seleĐtiǀitǇ faĐtoƌ, is usually described by the ratio of the retention (capacity) factors (κ) 
between the two compounds A and B peaks distances and determined by chemical characteristics; 
thus it is a priority to adjust retention (capacity) factors ;κͿ to improve the separation. When the 
amount of R achieved is 1.5, it is evaluated as good separation between the two compounds. The 
most useful optimization method is changing the solvent strength, for example the use of 
acetonitrile instead of methanol to increase the separation in reverse phase HPLC. Others include 
mobile phase solvent pH and column temperature adjustment. The column length and stationary 
phase composition can be changed when there are no improvements made by changing other 
variables [62]. 
 
1.3.1 High Performance Liquid Chromatography (HPLC) 
 
High Performance Liquid Chromatography (HPLC) is a liquid chromatography system with a pump, 
sampler injector, column compartment (column and oven), detector (such as diode array detector, 
fluorescence detector or MS detector) and computer control system, some of which have a vacuum 
degasser.  HPLC is an important technique for the qualitative and quantitative analysis for non-
volatile compounds, for instance natural product extracts, proteins, salts, polymers and 
pharmaceuticals.  HPLC separation procedure [Fig.1.5 (a) and (b)] involves injection of a liquid 
sample (5ul-10ul) into the column packed with fine particles (3-ϱ μŵͿ iŶ diaŵeteƌ aŶd high pƌessuƌe 
from a pump onto individual components of the sample through the column for separation. Finally, 
when these constituents are eluted/separated from the column, the detector measures the eluted 
amount (peak area) converted into an electrical signal output.  
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(a) 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
(b)                                                                                 (c) 
Fig.1.5 (a) Schematic of HPLC separation procedure and data obtained displays (b) HPLC instrument 
(c) HPLC-DAD (diode-array detection) components [reproduced from Agilent Technologies, Inc.]        
                                                               
1966 was the start of HPLC, when Piel published a method describing slurry-packed finely ground 
silica as a high liquid pressure (3500 psi) column to separate the samples [63]. Since the 1970s, the 
development of HPLC in column material and instrumentation in the hardware—pumps, detectors 
evolved. The octadecylsilane, [also called C18] was used as the stationary phase [64]. In the 1990s, 
sŵalleƌ paƌtiĐles ;less thaŶ Ϯ μŵͿ aŶd higheƌ pƌessuƌes ;as high as 100,000 psi) were applied in the 
separation.  
 
Most compounds can be separated by utilization of the four separation modes including reverse-
phase chromatography, normal-phase and adsorption chromatography, ion exchange 
chromatography and size exclusion chromatography. The method of choice is determined by the 
characteristics of chemical compounds to be separated: polarity, electrical charge and molecular 
size. Many herbal compounds [65] and biological samples (involving protein and nucleotides) [66,67] 
have been separated by reverse-phase chromatography (RPC).  Regarding RPC, the column is packed 
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with porous particles of silica gel in various shapes (spherics or irregular) of various diameters (1.8, 3, 
5, 7, 10 µM etc.) with various pore sizes (such as 60, 100, 120, 300), and the surface are covered with 
long covalently bonded alkyl chains (e.g. C18, C8, C3, phenyl, etc.) having a strong affinity for 
hydrophobic compounds (non-polar). The mobile phase is composed of water and organic solvent 
(methanol, acetonitrile).  Generally, the water solvent strength is the highest and an initial gradient 
run allows the organic solvent percentage to be lower, as a function of the time the organic solvent 
content increases, thereby raising the elution strength with polar components eluting faster than 
the less polar components [68].   
 
The HPLC solvent delivery programme options include isocratic or gradient conditions. Regarding the 
former conditions [69], the mixture of mobile phase is the optimized constant composition. The 
delivery system remains at equilibrium with the column during the separation procedure since the 
chemical constituents do not change. This method of chromatography has ideal reproducibility and 
accuracy for some sensitive and routine sample analysis such as caffeine and garlic constituents [70]. 
Many herbal compounds are complex mixtures including both very hydrophilic and hydrophobic 
compounds; but the HPLC system separates/resolves the individual constituents in reasonable 
separation times. Obviously, the composition of the mobile phase determines the retention times 
and resolution of the components. Therefore, the majority of chromatographic runs have been 
based on linear gradient conditions in the mobile phase in which the solvent strength is increased 
with time using a gradient elution separation. The retention factor (k or capacity) is usually improved 
by altering the amount of organic solvent (modifier) composition.   
 
 The Isocratic separation is suitable for quality control studies because the elution data 
reproducibility (e.g. retention time) by the separation conditions is stable.  In contrast, the gradient 
elution separation is suitable for the analysis of complex samples, applied to unknown mixtures and 
linear gradients that are most commonly used. During the gradient elution the measured baseline is 
less stable than in isocratic separations due to the frequent equilibrium changes between the mobile 
and stationary phases. Therefore, it is advisable to choose high purity solvents as the mobile phase 
to avoid contamination effects, run the pre-blank baseline at the start before any sequences of 
injections to ensure the baseline and system is stable. It is also essential to perform blank sample 
checks, performed by using the sample or standard solvent, to check the solvent purity. Some pH 
modifiers are always added to the mobile phase, such as acetic acid, formic acid or ammonium salts, 
and it is recommended to ensure that in blank samples there is a solvent UV absorption free to 
target analyst interference before sample or standard injections are made [71]. When preparing 
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samples, some analytes may be less soluble in the mobile phase, which is detrimental to the column 
and decreases separation reproducibility. The mobile phase solvents are suggested also for 
dissolving the sample and standards. All samples need to be filtered (e.g. 0.45um filter) prior to 
injection into the flow stream.      
 
The most common UV detection technique used is HPLC-DAD (diode-array detection), which 
measures the absorbance of UV wavelength against the concentration of the analyst as shown with 
the instrument [Fig.1.5 (c)]. 
 
Natural product analytes may ĐoŶtaiŶ ŶoŶďoŶdiŶg π* aŶd σ* oƌďitals iŶ the uŶsatuƌated atom 
bonds, aromatic groups, or functional groups. The electrons absorb the incident energy and rise to 
the higher energy state. The analyte UV energy absorbance is determined after the light passes 
through the sample. Analyte concentrations can be measured by the Beer-Lambert law 
equation: A = ε · c · l, where A is the aďsoƌďaŶĐe, ε is the aďsoƌptiǀitǇ ĐoeffiĐieŶt, Đ is the analyst 
concentration, and l is the length of the incident light through the flow cell containing the compound 
elution from the column. The absorptivity coefficient can be measured via standard calibration 
curves. So the same or similar substance concentrations in the unknown sample can be determined 
from the instrument response (absorbance) [72]. 
 
In the DAD the tungsten lamp (visible range) and the deuterium lamp (UV range) radiation is 
transmitted through the flow cell. The emission light is dispersed to individual wavelengths then 
reaches the diode-array for detection. In this way, the analyte absorbance signal can be measured 
for each component identification and quantitative analysis [73]. The detector sensitivity can be 
determined by the lamp and the manufacture design factors and the measures range from 190nm to 
700nm approximately. Concerns for sample detection involves the solvent cut-off value that is the 
analyte approximate wavelengths (nm) when they are specified below the absorbance that may be 
masked in the solvent. The solvents themselves absorb UV light in the lower wavelength range, such 
as the UV cut off value (nm) of water, acetonitrile values are 190 nm and methanol for 205 nm. 
Especially, under the condition of reverse-phase HPLC, the increased solvent in the mobile phase 
might increase its UV absorbance that may mask the low wavelength sample elution absorbance. 
 
1.3.2 Gas chromatography 
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The technique of gas chromatography (GC) was invented by James and Martin in 1952 and became 
the standard analytical method in many industries [74]. Separation of the components results from 
the distribution (partitioning) of each component between the mobile phase (carrier gas) and the 
stationary phase, but the system separation parameter control is mainly via the column temperature 
programme and gas flows. The basic requirement of GC analysis is sample and solvent volatility. 
Volatile samples generate gaseous mixtures containing the vapours of carrier gas, sample and 
solvent prior to passing on to the column. In general, the required amount sample is small for 
introduction onto the column and can be delivered by SPME fiber or microsyringe (about 1-20µl). 
After the sample is injected into the inlet, there are two injection modes available, split and splitless. 
The purpose of the two modes is to optimize the column separation. In the split mode, only a 
percentage of the gas mixture (from 1:1 to 1:500) is directed into the column, the remainder is 
expelled through the split outlet. This avoids column overloading and results in non-sharp and 
fronting peaks. When the split outlet is blocked, all gaseous are exposed to the column, this is the 
splitless mode and is mainly used in trace analysis due to sensitivity improvements. The carrier gas 
most commonly used is helium. Capillary column gives better performance efficiency, high 
resolution and are widely used [75]. The capillary column for GC consists of narrow tube coated on 
the interior with the stationary phase such as polysiloxanes or polyethylene glycols (i.e., 0.25 μŵ filŵ 
in a 0.32 mm tube). Under the same column length condition (almost 30m), the separation efficiency 
can be determined by the column temperature (ranging from about 50°C to 250°C) and the gas flow 
rate. Overall, temperature increases result in reduced retention time however the resolution quality 
decreases. The priority separations method usually chooses temperature gradients starting with the 
column relatively cool (about 40-50°C), and then gradually and constantly increasing the 
temperature stepwise (temperature programming); as the volatile component can interact with the 
stationary phase coating determined by polarity and boiling points. High gas flow rates reduce the 
component retention time also. There are many different detectors used for GC, for example flame 
ionization (FID), nitrogen–phosphorus (NPD) detection and others. 
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Fig.1.6 Schematic of a typical simple GC-MS [reproduced from Restek Corporation website]. 
 
1.3.3 Mass spectrometry (MS) [76,77] 
 
The basic configuration of the gas chromatograph and mass spectrometer (GC/MS), for which is used 
to separate the components in an unknown sample and MS as GC detector is illustrated in Figure 
1.6. Mass spectrometry is the most commonly used instrumental technique, for the identification 
and quantification of components in the mixture. The computer controlled GC and MS parameters 
such as separation programmes, injector temperature, MS scan mode and identification library 
match is available for two or more hyphenated GC-MS systems, for example GCxGC-MS and GC-MS-
MS systems.  
 
Mass spectrometers detect the ionized chemical species according to their mass to charge ratio 
(m/z), which include ionization source, mass analyser and ion detection system. First, sample needs 
to be ionized by various methods such as electron impact (EI), chemical ionisation (CI). EI is used in 
this research project at the standard ionization energy of 70 eV. Once the electrons collide with the 
molecular substrate (M), the loss one electron results in the molecular ion (M+) or it breaks into 
various fragments that contain smaller ions or it involves neutral fragment losses (eg. H2O, NH3). 
Then the ions are focused by a mass analyser for separation and resolution via their m/z value. The 
ion process includes quadrupole, time-of-flight (TOF) analysers, magnetic sectors and so on. For the 
Agilent HP 5973 Mass Spectrometer in the RMIT laboratory, quadrupole mass filters were used 
[Fig.1.7]. This consists of four parallel metal rods, of which two opposite rods have an applied 
potential of radio frequency(RF)  voltage and the other two rods have a potential of direct current 
(DC) offset voltage. The two pair applied voltage rods can select ions via m/z ratio. Only certain m/z 
ratio ions can travel down the quadrupole filter and reach the detector. After signal amplification, 
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the detector sends information to a computer recording all of the data produced and converts the 
electrical impulses into visual displays (mass spectrum). The mass spectrum expresses the fragment 
(ions) mass weight from the molecular with its characteristic relative abundances. The computer 
operations allow data acquisition with two scan modes, total ion chromatogram (TIC) and selected 
ion monitoring (SIM). The SIM mode utilizes selective monitoring of particular ions for example, a 
unique ion of the compound (e.g.intact molecular fragment) and high abundance especially higher 
mass. At present, data analysis programs run integration of chromatograms, and then compares the 
obtained spectra to reference spectral databases in library search to generate reports including 
identification and quality matches with reference library compounds.  
 
 
Fig.1.7 Configuration of quadrupole mass filter [reproduced from reference 76] 
Therefore, GC/MS can be used to analyse many low molecular weight compounds, applications that 
require compounds to be chemically stable at high temperatures and volatile. Many samples from 
complex matrixes (e.g. soils, herbal mixture, tissues etc.) contain many non-target ingredients that 
may interfere with the data acquisition and analysis of the compounds of interest. It is essential to 
treat these samples with solvent extraction or SPME techniques before GC/MS analysis.  
 
1.4    Thioflavin T (ThT) fluorescence assays 
 
The present methods to assay amyloid fibrils is to utilize thioflavin T (ThT) fluorescence, congo red 
binding, transmission electron microscopy (TEM), and Fourier transform infrared spectroscopy 
(FTIR); ThT dye is the most commonly used fluorescence detector for the identification and 
quantification of amyloid fibrils in vitro. 
The German physician scientist Rudolph Virchow ĐoiŶed ͚aŵǇloid͛ aŶd utilized iodine-sulphuric acid 
treatment in 1854, as the first amyloid dyes to stain abnormal organs [78].   During the 20th century, 
the amyloid fibrils were detected using congo red dye observed under polarized light microscopy, 
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because the dye binding produces a birefringence pattern that differentiates amyloid fibrils from 
other fibril proteins such as collagen and non amyloid deposits [79]. In 1959, the benzothiazole dye 
ThT was first used as a fluorescent marker to study amyloid detection in the kidneys [80]. The 
thiazole quaternary nitrogen of ThT selectively interacts with the hydroxyl groups of amyloid 
deposits to form hydrogen bonds and produce the specific binding within the grooves between 
solvent-exposed amino acid side chains of the amyloid fibril [81]. The florescence intensity increases 
are recorded [Fig. 8 (a), (b) and(c)] [82]. ThT assays are routinely applied to study amyloid fibril 
formation and the fluorescence intensity from the amyloid–ThT complex relates to the amount of 
amyloid fibril present. ThT can avoid many issues compared with congo red birefringence staining 
because amyloid deposits could be miscalculated due to sample thickness or orientation [83]. Also, 
the congo red dye can result in low reproducibility due to the staining background after washing. 
With the ThT assays, a phosphate buffer (10mM potassium phosphate, 150mM NaCl, or 50mM 
phosphate; pH: 5.8–7.0) are used to prepare ThT stock solutions (0.8mg/mL) in the phosphate 
buffer, needed to be covered with aluminium foil and kept at 4 °C refrigerator for less than 1 week; 
the working solution should be diluted 50 times and made fresh daily [84]. 
1.4.1 Fluorescence spectrometry measurements 
Fluorescence spectrometry is mostly used to identify or quantify an analyte in solution using a beam 
of light with a wavelength between 180 and 800 nm being transmitted through the sample solution 
in a cuvette. In fluorescence spectrometry [85,86] the light from an excitation lamp source that 
passes through a filter or monochromator for selective specific spectral band (excitation spectrum), 
is absorbed by the sample and measured. Some of this fluorescent light emitted by the sample 
passes through a second filter or monochromator (emission spectrum) from an angle at 90° and the 
detector measures the intensity of the emission, which is directly proportional to the analyte sample 
[Fig.1.8 (d)]. The samples include amyloid fibrils such as β-sheet-rich deposits after ThT was added, 
which fluoresces brightly with excitation and emission maxima at approximately 440-450 and 482-
490 nm, respectively; however other non-binding ThT in the aqueous solution, exhibit a weak 
fluorescence intensity and  lower (blue-shifted) excitation and emission maxima at 350 and 438-
440 nm, respectively [87].  Therefore, after ThT addition to the samples containing amyloid and 
measurement of the fluorescence excitation at 440-450 nm the emission is detected at 482- 490 nm. 
There are two common variations to this assay, (i) is a common measure with single time-point test, 
that is, the sample containing fibrils are diluted in ThT buffered solutions and then recorded at 
various time point readings (e.g. 24, 48, 72 hours); the other is fibrillation kinetics in real-time 
measurement. The fibrils formation can be tracked immediately.                                                                                                 
(a)                                                                                    (c)                                                                                                  
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        (b)  
 
                             
 
 
 
 
 
 
Fig.1.8 (a) The structure of Thioflavin T; (b)Magnified view of the ThT–ďiŶdiŶg β-sheet of β-sheet-rich 
deposits. The site near ThT-binding are shown as red sticks; (c) Essential component of a 
fluorescence spectrometer; (d) Characteristic increase in ThT fluorescence upon binding to amyloid 
fibrils. [reproduced from references 82,85,86] 
 
1.5     Coffee herbal functional beverages  
Coffee and herbs have a long human use history and have many benefits for human health according 
to research studies. They are a combination of natural products to produce a functional beverage for 
chronic consumption. In aim of this project is the development of an analytical method to identify 
and quantify the major beverage ingredients and to explore the human taste perceptions of a 
selection of coffee-herbal beverages. 
 
1.5.1 Coffee aroma induces/invites functional beverage usage 
 
Coffee is one of the most popular beverages in the world, that provides a stimulating effect on 
human sensory organs. Progress in coffee chemical analysis utilizing GC-MS, has resulted in more 
than eight hundred volatile compounds [88] being identified, many of which have been 
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demonstrated to contribute to coffee aroma. The aroma profile of coffee is composed of the 
following notes: sweet/caramel-like, earthy, roasty, smoky, fruity and spicy. The volatiles are from 
the classes of compounds including furans, sulphur compounds, pyrazine, ketones, phenols, pyrroles 
and comprise more than 60% of the total compounds. Kahweofuran, 2-furfurylthiol (roasty), 4-
vinylguaiacol (smoky), three alkylpyrazines (earthy), four furanones (sweet/caramel-like, spicy) and 
five aliphatic aldehydes (fruity), are important determinants of coffee odour [88,89]. 
 
1.5.2 Herbs are widely used ingredients/nutrients to improve health  
 
The documented benefits of liquorice and pharmacological studies indicate it is used to relieve 
cough, pain, and antiviral activity, oxidative stress, inflammation and has neuro-protective 
properties [90]. In the food industry, liquorice flavour is widely applied in candies or sweets and has 
long been used to flavour some dishes, drinks, and candies, as liquorice-like flavour in Western 
cuisines.  Ginseng has a leading position in the best-selling natural supplementary food products in 
the world. Ginseng and its extracts have been traditionally used to revitalize the body and mind, 
increase physical strength, memory and prevent aging, particularly in China, Korea and Japan. Ginger 
has a long and well document history consumed as a spice herb in cooking. Therapeutically it is 
widely used to control fever, pain, indigestion and infection diseases. 
 
1.5.3       Functional beverage sensory measuring 
 
The sensory properties are a major determinant for the coffee-herbal functional beverage people 
select and how much/often they are consumed. The functional beverage familiarity evaluations 
apply a hedonic scale to predict the sensory acceptance, consumer behaviour and eventually modify 
the beverage recipe further. The 9-point hedonic scales are applied to evaluate the aroma and 
flavour of the functional beverage and investigate their contributing factors for the long term 
functional beverage consumption. This is the one of most used methods to quantify consumer 
acceptance, which was first published by Peryam and Pilgrim [91] and has been used in academic 
and industrial consumer research in America and Europe. This hedonic scale describes an equal 
number of positive and negative categories with intervals of equal size. For example, 1=not at all 
liked, 3=slightly liked, 5=moderate liked, 7= like very much liked and 9=extremely likeable.  
 
1.6    Project hypothesis and scope 
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DeŵeŶtia iŶĐludiŶg Alzheiŵeƌ͛s disease is a sloǁ pƌogƌessiǀe ŶeuƌodegeŶeƌatiǀe disease 
commencing in midlife and it is difficult to reverse the process of loss of cognitive ability. However, 
we propose that if an effective treatment to reduce the rate of cognitive decline without any side 
effects could be found to delay and protect the brain from the dementia process, this would be 
highly desirable. Based on previous research, selected herbs and coffee to produce coffee herbal 
functional beverages against dementia were chosen for this project.  The selected herbal 
compounds will be measured by analytical methods such as GC/MS and HPLC/UV in the coffee 
herbal beverage [Fig.1.9]. Also, we will compare various herbal forms to ensure the highest 
effective/best available sources of the herbs are used in our research. It is important to determine if 
the herbal bioactive compounds can be extracted by safe and convenient methods (such as 
decoction, percolation and microwave heating). A small group of volunteers will be invited to 
provide their personal/subjective estimate of the coffee-herbal beverage sensory perception via 
hedonic scales as feedback to improve the beverage recipe.  
 
1.6.1 The selection criteria of the herbs used in functional beverages  
 
Firstly, the herbs used should have a long history of consumption without any health side effects and 
also be available as food supplements. Secondly, their selection is based on research evidence that 
these herbal compounds can cross blood brain barrier (BBB) into the brain. Also that they are 
effective in improving memory, are able to inhibit β-amyloid fibril formation or have anti-
inflammatory activity in the brain. Thirdly, the analysis of the main constituents present in the herbs 
will be studied to determine whether they can be maximally extracted into the coffee herbal 
beverage. Last but not the least, the herbs can produce favourable flavour and sensory perception, 
which will encourage continuous consumption. 
 
1.6.2      Key project questions   
 
Although the core task of the project is to analyse the bioactive compounds in coffee and in the 
herbs, the key questions addressed are not limited to their analysis. This is a multi-disciplinary 
pƌojeĐt, ǁhiĐh iŶǀolǀes the ŵediĐiŶal kŶoǁledge of Alzheiŵeƌ͛s disease pathologǇ, heƌďal 
pharmaceutical chemistry related to AD, natural product analysis (identification and quantitation) 
and human research ethics. 
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1. Why may coffee herbal beverages be chemopreventive/neuroprotective against dementia?  
2. What kinds of herbal compounds can be selected for preventing cognitive decline and what 
are the herbal compound selection criteria?  
3. What types of methods would be applied to measure the amount of target compounds in 
coffee herbal beverages, including instrumentation, procedure and data analysis?    
4. Can these effective bioactive compounds be extracted by a simple procedure such as a 
coffee machine or microwave oven?  
5. How can we measure the Đustoŵeƌs͛ sensory responses to the new beverage? 
 
                                                                                                                    
                                                                                                      Define the separation goal 
 
                                                                                                                Choose detector and 
                                                                                                                detector settings 
 
                                                                                                                 Sample pre-treatment 
                                                                                                      (The analyst extraction, solubility  
                                                                                                                             in solvent, purification and etal.) 
                                                                                                                  
                                                                                                      Choose LC or GC method 
                                                                                                                             (Including mobile phase, column type,  
                                                                                                                             operation setting and preliminary run) 
                                                                                                             
                                                                                                      Retention time adjustment                                                                          
                                                                                                                 (Including solvent strength, pH,  
                                                                                                                             temperature, standards preparing) 
 
                                                                                                                 Separation method validation  
                                                                                                                 (Including calibration curve creating,  
                                                                                                                              measuring accuracy, precision and etal.) 
 
                                                                                                                   
                                                                                                       The analyte peak area record  
                                                                                                                 and concentration calculation     
 
Fig.1.9 Typical sample preparation and separation steps involved in GC/MS and HPLC  
  
 
Sample Information 
 GC    or   HPLC 
Sample preparation
Separation method  
Optimize Separation
Routine test and 
data analysis 
Qualitative and quantitative 
method  
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2  
Coffee Herbal Bioactive Compounds for the 
Potential Prevention of Dementia  
 
 
Chapter 2 is concerned with the cause and mechanism of Alzheiŵeƌ͛s disease and herbal 
bioactivities against the disease, of the compounds selected/utilised for this project. This chapter 
describes the coffee herbal beverage compounds investigated. 
 
2.1   Multiple targets agaiŶst Alzheiŵer’s disease by natural products 
 
The German physician Alois Alzheimer first recorded the disease sǇŵptoŵs of Alzheiŵeƌ͛s disease iŶ 
1907, when he described the clinical case of Auguste Deter, in middle-age who had suffered serious 
memory loss that worsened. He demonstrated the shrinking of the outer layer and dramatic 
abnormal deposits around nerve cells in the patient͛s brain. The accumulation of amyloid 
oligomers/plaques and neurofibrillary tangles are hypothesised to contribute to the 
neurodegradation of neurons (nerve cells) in the brain and amyloidosis is hypothesised as the 
central causative factor of Alzheimer's disease [1]. A framework divides the disease into four stages: 
early dementia, mild dementia, moderate dementia and severe dementia. Recent research evidence 
has iŶdiĐated that soluďle Aβ oligoŵeƌs aƌe ŵoƌe toǆiĐ thaŶ mature fibrils [2,3] suggesting that 
oligomers should be a high priority target for designing potential antiamyloidogenic agents for AD. 
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Other AD hypotheses have been proposed including cholinergic, inflammatory /oxidative and 
adenosine hypotheses. However, the most widely accepted theory is the amyloid hypothesis [4]. 
These hypotheses are also the targets for natural products to prevent neurodegeneration.  
 
2.1.1 Target 1: Aŵyloid β peptide is produĐed ďy proteases  
 
Although the mechanism of AD is not fully understood, currently the aŵǇloid β peptide ;AβͿ is the 
main component of the amyloid plaques found in the brains of Alzheimer patients. Senile plaques 
ĐoŶtaiŶ ďoth AβϰϬ aŶd AβϰϮ [5] Fig.2.1. In particular, the iŶĐƌease of AβϰϮ oƌ AβϰϮ/AβϰϬ ƌatio leads 
to amyloid oligomer formation, that causes subtle and then increasingly severe and permanent 
changes of synaptic function [6].  Aβ is cleaved from the amyloid precursor protein (APP) by three 
proteases: α-secretase (the non-aŵǇloigogeŶiĐ pathǁaǇ shoǁŶ iŶ Figuƌe Ϯ.ϮaͿ, β-secretase (cleaves 
at the β-site of APP by the transmembrane enzyme aspartic proteaseϭ ;BACEϭͿͿ aŶd γ-secretase as 
illustrated in Figure 2.2b. APP is a single transmembrane polypeptide and can undergo a variety of 
proteolytic cleavages to secrete derivatives into the extracellular space [7]. β-Amyloid precursor 
pƌoteiŶ ;βAPPͿ is cleaved ďǇ β-secretase [8]. The γ-secretase enzyme cleaves the remaining 99 amino 
acid C-terminal fragment of APP ;CϵϵͿ to AβϰϬ oƌ AβϰϮ [7] and a C59 residue. The APP is cleaved by 
α- seĐƌetase, ƌeleasiŶg the soluďle APPα peptide fƌagŵeŶt aŶd C-terminal fragment further cleaved 
ďǇ γ-secretase, producing p3 nontoxic fragments [10]. Theƌefoƌe, iŶĐƌeasiŶg α-secretase activity can 
deĐƌease the leǀel of βAPP aŶd eŶhaŶĐe ŶeuƌopƌoteĐtiǀe effeĐts, ǁhile β- seĐƌetase aŶd γ-secretase, 
endoproteolyze APP to liďeƌate the Aβ peptide Fig.Ϯ.Ϯ. There is evidence that the iŶĐƌeased Aβ 
pƌoduĐtioŶ aŶd eŶhaŶĐed depositioŶ of β-sheet amyloid is linked to β- secretase 
upregulation/activity in sporadic AD patients [11]. 
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Fig. 2.1 Amyloid cascade hypothesis [reproduced from reference 12] 
 
Fig.2.2 Enzymatic processing of transmembrane APP: the non-amyloidogenic (A) and amyloidogenic 
pathways (B). [reproduced from reference 13] 
 
2.1.2 Target 2: Neurodegeneration is accelerated by inflammation and oxidative stress     
 
It has long been known that the damage of brain tissue and the deposition of highly insoluble 
aďŶoƌŵal ŵateƌials ;like daŵaged ŶeuƌoŶs, Ŷeuƌitis, aŵǇloid β peptide deposits aŶd ŶeuƌofiďƌillaƌǇ 
tangles) are powerful microglia activators [14]. Microglia are the immune cells of the brain where 
local inflammatory responses (microgliosis and astrocytosis) are observed. As microglial activation in 
particular, are core features of AD and secrete increased levels of multiple inflammatory 
mediators[15], Aβ iŶduĐes the eǆpƌessioŶ of pƌoiŶflaŵŵatoƌǇ ĐǇtokines including IL-ϭβ, IL-6, TNF, 
oxygen free radicals and nitric oxide; also the induction of inflammatory enzyme systems such as the 
nitric oxide synthase (iNOS) and the cyclooxygenase enzyme (markers of inflammation COX-2). 
Overexpression of interleukin (IL)-1, IL-6 and tumour necrosis factor (TNF-αͿ lead to dysfunction and 
neuronal death [16,17]. Afteƌ the ĐoŶǀeƌsioŶ of a ͚ƌestiŶg͛ ŵiĐƌoglia iŶto aŶ ͚aĐtiǀated͛ pheŶotǇpe, it 
can be observed that the increase of expression of amyloid precursor protein aŶd its β-secretase 
Đleaǀed pƌoduĐts ;sAPPβsͿ as ǁell as Aβ oligoŵeƌs lead to aĐĐuŵulatioŶ of Aβ. However, normally 
this is reduced by the α-secretase cleaved products (sAPPas) in human neuronal cell lines [18]. There 
is a correlation between diminished cognitive status and microglial activation in mild cognitive 
impairmed patients [19]. Astrocytes, also known collectively as astroglia, are comprised of a highly 
abundant population of glial cells and serve an array of important functions including the regulation 
of extracellular ion concentrations, synaptic remodelling (addition and removal of synapses), and the 
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maintenance of protective barriers like the blood-brain barrier [20]. Senescent astrocytes were 
found accumulated in brain tissue from aged individuals and AD patients [21]. Anti-inflammatory 
approaches have been developed that may not cure AD directly but slow the progression or delay 
the onset of this devastating disorder. More than 50% of the benefit from taking non-steroidal anti-
inflammatory drugs (NSAIDs) is to prevent the onset of dementia with long-term usage against AD 
[22].  
 
Oxidative stress is produced by the imbalance between production and removal of free radicals and 
reactive oxygen species (ROS), such as superoxide anion (O2
-), hydrogen peroxide (H2O2) and 
hǇdƌoǆǇl ƌadiĐal ;OH•Ϳ; the important sources of these are from glia cells inflammation and aging in 
the brain. Proteins and lipids are targets for oxidative attack increase the risk of neurodegenerative 
diseases occuring and result in protein misfolding [23]. During early dementia stage, it  can be 
observed that oǆidatiǀe daŵage pƌeĐedes Aβ depositioŶ due to ŵitoĐhoŶdƌial ŵetaďolisŵ 
dysfunction and apoptosis [24]. Many natural products  that can eliminate free radicals and reactive 
oxygen species (ROS), are antioxidants [25]. 
 
2.1.3 Target 3: Cholinesterase inhibition agaiŶst Alzheiŵer’s disease 
 
 Cholinesterase inhibitor drugs are widely applied for treating the symptoms of AD and are licenced 
AD drugs. Generally speaking, acetylcholine is an important neurotransmitter for cognition and 
memory, and patients with dementia, AD have low levels of acetylcholine. If natural compounds can 
sustain acetylcholine levels via cholinesterase inhibition, this sustains neurotransmission between 
nerve cells, which in turn, may temporarily ameliorate or stabilise the symptoms of dementia.  
 
2.1.4 Target 4: Adenosine receptor inhibition agaiŶst Alzheiŵer’s disease  
 
Adenosine, an endogenous nucleoside, plays important roles in synaptic transmission and neuronal 
excitability in glia and neurons, which activate adenosine receptor including A1, A2A, A2B and A3 G-
protein coupled receptors to have effect on cognition, memory and neuronal degeneration [26]. 
Some research has suggested that the receptors of A1 and A2 were inhibited to improve cognitive 
function or decrease cognitive impairment [27].  To prevent neuron damage, A1 adenosine 
receptors activation tends to restrain glutamate release that hyperpolarize neurons by a 
predominantly presynaptic action, while A2A adenosine receptors inhibition are more likely to 
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decrease transmitter release and postsynaptic depolarization and promote synaptic plasticity [28].  
These two receptors are composed of dimers with different metabotropic receptors operated by 
other neurotransmitters such as glutamate, NMDA and nitric oxide [29]. Therefore, adenosine 
receptors could promote the inflammatory process regulation and pro-inflammatory cytokine 
release such as interleukins and TNF and promote cognitive impairment during brain damage. It has 
been observed that A1Rs expression is reduced in cortical and hippocampal regions but A2ARs 
increase in limbic regions in aged animals. It is proposed that a new target for the development of 
new therapies that A1 adenosine receptor (AR) agonists, A2AR antagonists and A3AR antagonists for 
neuroprotection can be based on the adenosine neuromodulatory system. In the context of this 
project, coffee is neuroprotective, as caffeine is a non-selective inhibitor of adenosine receptors and 
is a protective agent against AD [30,31]. 
 
2.2     Coffee protects against dementia 
 
There are over 25 varieties of coffee plants known, although only two are exploited in economically 
significant quantities: Arabica (Coffee Arabica) and Robusta (Coffee by the canephora plant).  Coffee 
has long been demonstrated to possess various mechanisms against AD. We have focused on coffee 
protection against dementia and Aβ iŶhiďitioŶ as ĐaffeiŶe ĐaŶ cross the blood-brain barrier (BBB) 
and reduce the symptoms of inflammation and oxidative stress in brain.  
 
2.2.1     Caffeine and coffee compounds exert protective effects against AD 
 
Caffeine is rapidly absorbed from the gastrointestinal tract in the stomach and small intestine, and 
distributes rapidly in all tissues including the brain. In rodent studies aged cognitively-impaired AD 
mice exhibited memory restoration and lower plasma aŶd ďƌaiŶ Aβ levels following 1–2 months of 
caffeine treatment (the human equivalent of 500 mg caffeine or 5 cups of coffee per day). It 
suppresses ďoth β- aŶd γ-secretase levels [32,33]. Caffeine can iŶĐƌease ďƌaiŶ Aβ ĐleaƌaŶĐe at the 
BBB and decrease the inflammatory cytokine levels in the hippocampus [34,35]. It is a non-specific 
adenosine antagonist, its neuroprotective effect is likely to be the blockade of adenosine A2A , which 
play a role in the  control of neuroinflammation [36,37]. Trigonelline, a coffee constituent and a 
component of the popular Indian curry spice, [38]. Both caffeine and trigonelline are investigated as 
anti-AD drug candidates [39]. Trigonelline docking ǁith Aβ42 interacts with key residues (His6, Tyr10, 
His13 and His14) and alters its structure to inhibit its aggregation [40]. After 15 days of orally 
48 | P a g e  
 
administered trigonelline (500 mg/kg) there was iŵpƌoǀed ŵeŵoƌǇ iŶ ŵiĐe iŶduĐed ďǇ Aβ ;Ϯϱ–35) 
injection [41]. Chlorogenic acid (9mg/kg) a major polyphenolic component in coffee, significantly 
improved the cognitive impairment of experimental models of AD induced by scopolamine 
(0.5mg/kg) in mice and involved anti-AChE and anti-oxidative mechanisms [42]. The investigation 
indicated that these coffee compounds including chlorogenic acid, quercetin, caffeine, can reduce 
the release of TNF-α aŶd IL-6 from the activated microglia and astrocytes [43].  
 
 
 
 
   
Fig.2.3 Structures of caffeine, trigonelline and caffeic acid           
 
2.2.2     Human studies of neuroprotection of coffee against dementia  
 
According to the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) study data after an 
average follow-up of 21 years (midlife visit), a total of 61 cases were identified as demented (48 with 
AD) of 1409 individuals. Moderate coffee drinkers (3-5cups/day) at mild life had a 65–70% decreased 
risk of dementia and AD compared with those drinking no or only little coffee (0-2 cups/day) [44]. Aβ 
levels were not seen in human blood following acute caffeine administration. Other survey analysis 
also concluded that coffee consumption is associated with a reduced risk of AD [45]. Interestingly, 
Caffeine intake was associated with a better cognitive response to acetylcholinesterase inhibitors 
(AChEIs) in AD women, according to northern Taiwan clinical trial that included 234 mild to 
moderate AD patients studied from 2007 to 2010 [46]. 
 
 2.3     Liquorice protects against dementia 
 
Glycyrrhiza is a genus of about 18 accepted species in the legume family, of which Glycyrrhiza glabra 
is a species native to the Mediterranean region called Licorice (liquorices); G. Echinata is a Russian 
licorice and G. Uralensis are known as Chinese Licorice. More than 400 compounds have been 
identified from Glycyrrhizin species; including flavonoids,  glycyrrhizic acid (GA )and glabridin. All are 
utilized for major medicinal purposes [47]. Glycyrrhizic acid contains both hydrophilic (glucuronic 
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acid) and hydrophobic (glycyrrhetic acid) regions, which can form stable inclusion complexes with 
various organic molecules because GA in solution can create cyclic structures [Fig.2.4] [48]. It may be 
reasonable to propose that this molecular characteristic provides not only high stability but may 
reduce side effects or improve the therapeutic efficiency.  
 
Fig.2.4 β-Glycyrrhizic acid converts to a stable inclusion complex with other molecules (GA͞doŶut͟ 
ring) [reproduced from reference 48] 
 
2.3.1 Liquorice compounds that ŵay affeĐt Alzheiŵer’s Disease 
 
Liquorice intake (150 mg/kg for 7 successive days) [49] inhibited acetylcholinesterase (AChE) in 
brains of mice and prevents AβϮϱ-35-induced (25uM) apoptosis in PC12 cells under 1mg/ml [50,51]. 
Glycyrrhizic acid (GA) (5,10 mg/kg) [Fig.2.5], which is the major active component of liquorice 
suppressed the inductions of TNF-α, IL-ϭβ, COX-2, and iNOS to have the anti-inflammatory effects 
[52] and protect neurons via anti-oxidative [53]. Some reports show that GA can be metabolized into 
ϭϴβ-glycǇƌƌhetiŶiĐ aĐid ;ϭϴβGAͿ, aŶotheƌ ŵajor active compound in liquorice ďǇ β-D-glucuronidase in 
intestinal bacteria [54]. ϭϴβGA can ďiŶd to ŵiŶeƌaloĐoƌtiĐoid ƌeĐeptoƌs ;MRsͿ aŶd ϭϭβ-
hydroxysteroid dehydrogenase type-ϭ ;ϭϭβ-HSD1) distributed mainly in neurons, moderately in 
astrocytes of the hippocampus [55]. Diammonium glycyrrhizinate (DG) (0.01μg/μl) attenuates 
ŶeuƌoŶal iŶjuƌǇ ǀia deĐƌeasiŶg ROS pƌoduĐtioŶ iŶduĐed ďǇ Aβϭ-42(2uM) and improved cognitive 
iŵpaiƌŵeŶt iŶ Aβϭ-42 induced AD mice with 10mg/kg for 14 days [56]. Liquiritigenin (50μM) 
effectively protects against glutamate-induced (5mM) hippocampus-derived neuronal cell line (HT22 
cells) early apoptosis via inhibition of Ca2+ influx, intracellular reactive oxygen species (ROS) 
production, and lipid peroxidation in mice [57]. It is similar to isoliquiritigenin (1-ϮϬμMͿ that 
iŶhiďited Aβ ;Ϯϱ-35)-induced (10μM) neuronal apoptotic death in relation with Ca2+ and ROS [51].  
Liquorice-derived dehydroglyasperin C (DGC) has effects on inflammation-mediated  
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neurodegeneration and also reduces cytotoxicity and ROS generation [58]. 
 
 
 
 
 
 
Fig.2.5 Glycyrrhizic acid (GA) and Glabridin  
 
2.3.2 Human studies of liquorice protection against dementia   
 
Liquorice of 260ml hot water extract taken for 8 weeks, decreased in 20 healthy male smokers (aged 
20-60) blood sample plasma levels of conjugated dienes (a maker for lipid peroxidation), that might 
be ascribed to its antioxidant compounds [59]. According to the 2010 edition of the Chinese 
Pharmacopoeia, liquorice is recorded at position 320 of 1062 prescriptions as a principal or assistant 
drug [60]. It is reported that 10 mg glycyrrhizic acid intake daily is safe for most healthy adults [61]. 
 
2.4     Ginseng protects against dementia 
 
Panax ginseng C. A. Meyer (Asian ginseng) and Panax quinquefolius L. (American ginseng) are the 
two most recognized ginseng type around the world [62].  The key active ingredients of ginseng are 
known as saponins or ginsenosides such as Ginsenoside-Rg1 (G-Rg1), Ginsenoside-Rg2 (G-Rg2) and 
Ginsenoside-Rb1 (G-Rb1), Re, Rd [Fig.2.6a]. These compounds are known to improve attention, 
processing, memory and preventing memory impairment [63]. Asian and American ginseng contain 
similar ginsenoside profiles but Rb1 is richer in American ginseng [64.]    
 
2.4.1     Ginseng compounds that ŵay affeĐt Alzheiŵer’s disease 
 
Red ginseng is produced by steaming raw ginseng, the extract (100mg/kg) significantly ameliorated 
young and aged rats with hippocampal lesions in the place-navigation deficits (PLT), because 
expression of inflammatory cytokines such as TNF-α, IL-ϭβ, aŶd IL-6 were reduced in the serum level 
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[65]. Ginsenoside composition from steamed ginseng also can inhibit acetylcholinesterase (AChE) 
and butyrylcholinesterase (BChE) activities [66].  Ginsenoside Rg1 (10, 20 mg/kg) promoted spatial 
learning and memory on ovariectomized rat model of AD after treatment 6 weeks; It can reduce 
Aβϭ-42 generation by increasing ADAM 10 expression ;oŶe of α-secretase) and decreasing BACE1 
expression ;oŶe of β-secretase) [67,68] ginsenoside Rb1 can inhibit liver cells fibrosis via  decrease 
plasma aminotransferase activities and inflammation [69]. The long-term pretreatment with 
ginsenoside Rb1 attenuated the aged mice brain impairment via extensive anti-oxidant activity. 
Ginsenoside Rb1 selectively inhibited the activity of L-type voltage-gated calcium channels to decline 
the damage in hippocampal neurons [70,71]. In vitro, ginsenoside Rb1(0.1, 1mM) inhibited β-
secretase activity [72] and protected agaiŶst AβϮϱ-35 induced (25 or 50µM) cytotoxicity in PC12 
cells, Ginsenoside Re(0.1-100uM) [73]. The inhibitory effect of ginsenoside Rg2 (0.2 mmol/L) against 
the foƌŵatioŶ of Aβϭ–40 induced by glutamate in PC12 cells [74]. Rg2 (2.5, 5 and 10 mg/kg) also 
prevented memory impairment in a rat model with vascular dementia via modulating the expression 
of apoptotic related proteins [75].  
 
 
 
 
 
 
 
 
 
 
(a)                                                                     (b) 
Fig.2.6 (a) Ginsenosides Rďϭ, Rgϭ; ;ďͿ α-PiŶeŶe, β-Pinene and Camphene 
 
2.4.2     Human studies of ginseng protection against dementia  
 
Endogenous antioxidants in human plasma like glutathione peroxidase (GPx), catalase and 
superoxide dismutase (SOD) activities were significantly increased after Ginseng (6 g/day) 
supplement for 8 weeks because ginseng has effect on regulation of immune system to enhance 
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resistance to illness [76,77]. In AD patients, red ginseng including Rb1 (1.96%), Rb2 (2.18%) Rg1 
(0.49%), and Rg2 (0.13%) treated with 9 g/day the dose lasting 12 weeks, significantly improved the 
Alzheiŵeƌ͛s Disease AssessŵeŶt SĐale ;ADASͿ, CliŶical Dementia Rating (CDR) scale [78]. Red Ginseng 
is a cognitive enhancing saponin used as complementary anti-dementia medication. Panax ginseng 
administration for 4 weeks was shown to be safe, tolerable, and free of any untoward toxic effect in 
healthy male and female volunteers [79].  
 
2.5     Ginger protects against dementia  
 
Ginger (ginger root) is the rhizome of the plant Zingiber officinale and contains many potentially 
bioactive compounds. Studies have shown that the volatile oil of ginger contains up to three percent 
of fragrant essential oil including monoterpeŶoid fƌaĐtioŶ ;α-pinene, camphene, geraniol, geranial 
and zingiberene) [Fig.2.6b]. Overall, the in vitro evaluation of the ginger extract expressed high 
antioxidant activity, inhibited AChE and BChE and activity against the foƌŵatioŶ of Aβ oligoŵeƌs ǁith 
the ThT binding assay, which showed the neuroprotective functions [80].  
2.5.1    Compounds in giŶger that ŵay affeĐt Alzheiŵer’s disease 
  
The ginger component such as 6-gingerol has anti-inflammatory activities [81]. Furthermore, ginger 
extract profoundly blocked expression of IL-ϭβ aŶd COX-2 by fibril Aβ ;ϭ-42) activation with THP-1 
cell line preclinical studies, with properties similar to human microglial cells [82]. It should be 
possible to reduce or delay the progression the pathogenesis of AD through anti-inflammatory 
approaches. 6-Shogaol (10 mg/kg/day) for 5 consecutive days significantly decreased activation of 
microglia and astrocyte visualized by rat monoclonal anti-CD11b (Mac-1) compared to after 
stereotaxic injection of Aβ peptide ϭ–42 (10µM, 3µl). The same consequence was observed in the 
hilar region of dentate gyrus (DG) in hippocampus. Meanwhile, 6-shogaol reduced memory 
iŵpaiƌŵeŶt ǁith Aβ peptide ϭ–42 hippocampus lesion in mice through the passive avoidance test. 
This has also been confirmed in the scopolamine-induced memory impairment model by passive 
avoidance test.  Neuron growth factor and synaptophysin levels were significantly elevated in the 6-
shogaol treatment of mice hippocampal tissues [83]. In clinical trials, ginger is often advocated for 
use for its beneficial effects against nausea and vomiting. 
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3 
The Analysis of Herbal-Coffee Beverages 
 
 
We utilized coffee and herbs, including liquorice, ginseng and ginger, to produce herbal coffee 
beverages. Quality control is one of the most important aspects for beverage usage and 
modification. According to the effective bioactive compounds for preventing dementia described in 
chapter 2, the bioactive compounds caffeine, trigonelline, glycyrrhizic acid ginsenoside Rb1 and 
camphene were set as the analysis compounds. A herbal quality valuation method choose one or 
two pharmacologically active components from the herbal mixtures [1]. The method has the 
advantage to ensure the active compound concentrations are known and are reproducible providing 
beverage quality assurance as the concentrations of the bioactive compounds determines the 
potential pharmacological effects.  
 
Chromatographic techniques have been developed to assess qualitative and quantitative analysis of 
these herbal compounds over the past decades. For the analysis of the bioactive compounds in 
beverages several different techniques have been applied, including liquid chromatography with UV 
absorption detection (LC/UV), SPME-gas chromatography-mass spectrometry (SPME-GC/MS) as the 
most commonly validated methods. In this chapter the results of the analysis of the coffee-herbal 
beverages are described along with a preliminary test for natural product inhibition of amyloid fibril 
formation. 
 
3.1     The validation parameters of the chromatographic method  
 
3.1.1          Quantitation using external standards 
 
The reason analytical standards are employed is to identify the retention time of the substance of 
interest and quantify its chemical peak area (or height), when compared with the pure reference 
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substance in an unknown matrix /solution, using chromatography. The standard analysis methods 
can be used in two ways, either as an internal standard or as an external standard. In the external 
standard  method a series of the pure chemical, with the sample solution in varying ratios, then run 
the blank and the combination of standards and samples respectively. The standard absolute 
response is then plotted against the ratio of the substance concentration to provide the calibration 
curves [2]. Regression analysis is used to define the relationship between the variables, and the fit 
assessed by the coefficient of determination (R2) of the amount of unknown samples can be 
calculated using  the regression.  
  
With the external standard method, the reference standard (or standards) must have the same 
retention time as the  the substance in the sample using the same chromatographic conditions. In 
addition, the substance accuracy (recovery rate) should be assessed and be in acceptable range 
(100±2%) because errors could be induced by the standard concentrations preparing or injection-to-
injection variation in each  test. The detector is assumed to supply the same response to the 
standard and the samples and provide a linear response for the range of the standards measured. 
The equation used to calculate target analysis is, C(u)=A(u)/A(std)×C(std) Assuming, the response 
index of the detector is unity, where A(u) is the peak area of target analyte in unknown sample, A 
(std) is the peak area of standard and C (u) and C (std) are the concentration of target analyte in the 
unknown sample and standard solution respectively [3]. However, it is necessary to understand the 
behavior of the response factor as the concentration or amount of target compound and external 
standard are variable. The behavior of the response factor allows one to set limits on acceptance 
range (similar to confidence interval) of the concentrations of the standards batch. These 
parameters include identity confirmation, accuracy, precision, linearity and detection limit.  
 
3.1.2        Peak identification [4,5] 
 
In chromatography, the evidence provided for peak identification is that that the retention time of 
the unknown peaks are the same as the known standard peaks. However some other compounds 
could have similar retention times. Spectrometric methods are applied to confirm the detected 
compound is the same as the analyte. For example, DAD detectors are classical spectrometric HPLC 
detectors, which supply information about structural features of compounds from their UV spectra. 
Mass spectrometry is also another powerful method for identity confirmation, which provides mass-
to-charge (m/z) values of ions fragment from the analyst molecules and the intact molecular masses 
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with little fragmentation can be observed as well.  The mass spectrum is mass-to-charge (m/z) values 
(x-axis) against intensity of the ions (y-axis) [6].  
 
Many GC/MS instruments utilize electron ionization (EI) mode to form a radical cation via collision-
induced dissociation with standard ionization energy of 70 eV. The intensity ratio of ions derived 
from the same compound should be consistent under the same EI, which result in fragmentation in a 
characteristic and reproducible way. These fragments are able to be scanned via full scan mode or 
selected ion monitoring (SIM) mode. The MS spectrum can then be compared to large reliable 
reference libraries obtained with different instruments because of standardized EI, and the GC/MS 
analysis programme can provide a with the reference substance [7]. Additionally, The MS spectra of 
samples can compare the presence of these ions and their relative intensities with standard peaks. 
Some guidelines recommend 2–4 ions be selected for compound identification, and the ions 
intensity should be in the acceptable range. The intact molecular fragment or high m/z value ions 
are selected as specific, but the low abundant ions (relative intensity <5%) are not usually used for 
identification. The normal neutral losses (e.g. H2O, NH3) do not have a characteristic diagnostic value 
and are also not used for identification [8].  
 
3.1.3       Accuracy (recovery) [9,10] 
 
The accuracy analysis is an analytical method in the matrix in which the targets compounds test 
results obtained are compared to the the true value. The spike recovery analysis is the most used 
method for determining in herbal compounds studies, in which the recovery is based on the known 
amount of the analyte working in the linear range of detection. The evaluated constituent of interest 
is placed in the blank matrix and then as a percentage of the true value increase in the matrix 
(spiked).  The assay analyses are performed over a range of 50-150% of the target concentration 
calculation under the chromatographic conditions. Accuracy criteria for drug substances and drug 
products are recommended to be performed in 100 ± 2% and at least in triplicate as stated in FDA 
Guideline for Submitting Samples and Analytical Data for Methods Validation.  
 
In the present analysis, the accuracy is measured by spike recovery with the ratio of standards 
concentrations at the 50, 75 and 100% levels (the concentrations are 40ppm, 60ppm and 80ppm 
each). A series of different mixed standard solutions (caffeine, trigonelline, GA and Rb1 in HPLC) 
were prepared with known added amounts (20ppm) and injected in triplicate. The herbal target 
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compound peak area will increase by approximately 50, 75 and 100%, and correspond to the ratio of 
concentration levels rising respectively. Regarding the semi-quantitative camphene analysis by 
SPME-GC/MS for ginger, the higher standard range is also set at the 50, 75 and 100% levels.  The 
purity of standards can also affect accuracy. In the HPLC and GC/MS investigation, the five major 
standards were purchased from a commercial supplier, Sigma-Aldrich at >97% except for GA (>70%). 
 
3.1.4         Precision [11,12] 
 
The precision of an analytical method assess the closeness of agreement between a set of replicate 
measurements performed under the separation conditions. Precision may be discussed at the two 
areas: one is repeatability (method precision), which carry out the analysis at the three levels (50%-
150%) and performed in triplicate; the other is intermediate precision which examines the analysis 
on multiple days and maybe with a different operator, equipment or column. The agreement is 
ŵeasuƌed iŶ teƌŵs of ƌelatiǀe staŶdaƌd deǀiatioŶ ;RSD%Ϳ aŶd the ĐalĐulatioŶ eƋuatioŶ: RSD% = σ/μ × 
ϭϬϬ%, ǁheƌe the σ is the aŶalǇsis standard deviatioŶ ;SDͿ aŶd μ eǆpƌess the ŵeaŶ. IŶ geŶeƌal, the 
RSD% accepted criteria are less than 10% in the combined assay, which is contributed to by variation 
in days of sample preparation, column or operator.     
 
3.1.5          Linearity [13] 
 
The Calibration curve is defined by the model equation. R2 measures how well the model fits the 
data. The liŶeaƌitǇ of the ŵodel is deteƌŵiŶed ďǇ a ͚laĐk-of-fit͛ test ǁhiĐh deteƌŵiŶes ǁhetheƌ a 
linear equation is the best fit for the data. In chromatography, the detector linearity represents the 
range of concentrations of substance that will give a linear response. This is also defined as the 
specific concentration range.  
 
In the project, the DAD standards concentration range was set between 20ppm to 100ppm. The 
method chosen ensured that the output of the plot of peak area is proportional to the concentration 
(or mass of solute passing though it per unit time) and that is the chemical standards injection (such 
as caffeine, trigonelline, GA and Rb1) were eluted from the column in a reasonable time. The 
calibration curves for HPLC utilized a five concentrations batch and represent the standard individual 
performance to the DAD and measurement of goodness of fit (coefficient of determination (R2)). 
Generally, these responses from each analytical method were matched to the linear regression 
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model, y = mx + b, where y refers to DAD response (peak area), x represents standard 
concentrations batch and m and b relate to the best fit slope and y axis intercept for each calibration 
curve respectively. Strictly, the quantitative method accepted a good R2 criteria of 0.99 or greater, 
but in some semi-quantitative analysis, R2 > 0.97 can also be acceptance to be linear. The 
measurement accurately should be validated by other analysis methods for comparison. 
 
3.1.6           Limits of detection [14, 15] 
 
The term ͚Liŵit of DeteĐtioŶ͛ [LOD] refers to the lowest concentration of the analyte that can be 
reliably distinguished from the noise (baseline). In chromatographic analysis, the common approach 
to estimate LOD, via linear regression method calculation, assumes that the instrument response y is 
linear against the standard concentration x over the range. The linear equation expressed as: y = 
mx+b, where m is the slope of the calculation curve. LOD calculations relate to Signal to Noise ratio 
(S/N), which is the analyte peak against the baseline noise and should be at least 3 times higher than 
baseline as the threshold measurement caused by instrument parameters such as lamp aging, the 
column, the mode of detection and even manufacture. The valuation analysis of LOD can be defined 
by the eƋuatioŶ: LOD=ϯσ/ŵ; ǁheƌe σ ƌepƌeseŶts the standard deviation of the analyst response and 
m also expresses the slope of the calculation curve. The SD of response is accepted to utilize the 
lowest concentration in the standards range, which is the closest to the zero during the assessment. 
Therefore, LOD is important to evaluate whether the analytical method is suitable for analytical 
purposes.   
 
3.1.7             Kováts index (retention index) [16,17,18] 
 
Kováts index or Kováts retention index refers to normalization of the component retention times in 
GC via logarithmic calculation with n-alkanes as standards. Retention time is essential for the 
identification parameters of the component and should always be reproducible under the same 
analysis conditions. However, the retention time is determined by various factors including the 
characteristic component, column (e.g. length, diameter, stationary phase and thickness of film) flow 
rate gas carrier and oven temperature programme.  It is a widely accepted method to use relative 
retention times to reduce the influence of these factors. The equation is RRT= standard RT/sample 
RT, where the standard is one of the same/similar to the sample. The disadvantage is the standard 
variability of different samples.  
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Swiss chemist Ervin Kováts who introduced this concept of the retention index system concept 
during the 1950s. This indicates the retention behaviour of the various substance determined by a 
uniform scale of a series related closely standards. In other words, the well-behaved series of 
standards (such as n-alkanes) are measured on several instruments and the standards as reference 
describe the relation with the elution sample in one instrument via system-independent constants.  
The the similar constant can then be produced according to the association between the reference 
(the standards e.g. n-alkanes) and the samples on another instrument. Therefore, the Kováts index 
uses two standards (n-alkanes) elution times to adjust the elution behaviour of the component in 
the unknown sample and create system-independent constants, which locate before and after the 
component. The constant (Kováts index) has the advantage that the same component should have a 
close index values on different GC instruments whatever the various samples or separation 
conditions and overcomes the instrument parameters influences mentioned above. It is important 
to choose the right n-alkanes as reference standards; it should be an increasing homologous series 
for instance alkane (C8-C20) and in high purity (analytical grade).   
 
The Kováts index can be calculated using the equation below, based on the log-linear relationship 
between number of carbons (n) in an n-alkane homologous series and retention time. 
 
 
Where: I is the Kováts index, n is the number of carbon atoms in the alkane (before the component), 
t͛Nn is the loǁeƌ ĐaƌďoŶ atoŵs ƌeteŶtioŶ tiŵe ;ďefoƌe the ĐoŵpoŶeŶtͿ iŶ the alkaŶe, t͛N(n+1) is the 
higher carbon atoms retention time in the alkane (after the component), and the component elutes 
between Cn and Cn+1.  There are software programs available that then generate I from the retention 
times.  
                  
3.2     Introduction to the coffee and herbal compound analysis method  
The heterocyclic components of coffee (trigonelline, nicotinic acid and caffeine) concentrations were 
determined by RP-HPLC- diode-array detection of the brewed beverage sample [19,20]. The mobile 
phase used was methanol or acetonitrile, timeline limit in one hour, the flow rates between 1.0 and 
2 mL min−ϭ and thermostatically controlled columns normally kept at ambient or slightly above room 
temperatures; trigonelline analysed at 266nm and caffeine at 275nm [21,22]. 
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Triterpene saponins and flavonoids are the major components in liquorice; the concentrations of 
which are determined by plant growth, harvesting time and time of processing [23]. The main 
bioactive constituent GA is a triterpene saponins, which can be separated on reversed-phase C18 
eluted with isocratic methanol: MQ water: (0.2 M ammonium acetate or acetic acid) (67:33:1) and 
detected at 254nm. Because of the acidity of saponins, modifiers (such as ammonium acetate or 
acetic acid) were usually used to suppress their ionization and to achieve optimal separation [24,25]. 
 
The concentrations of seven major ginsenosides (Rb1, Rb2, Rc, Rd, Re, Rf, and Rg1) were analysed by 
reversed-phase HPLC ǁith staŶdaƌd Cϭϴ ĐoluŵŶs ;ϭϱϬ oƌ ϮϱϬ ŵŵ × ϰ.ϲ ŵŵ; ϱμŵͿ aŶd the ŵoďile 
phase of acetonitrile and water with buffer was used with an optimized gradient elution program. 
Diode-array detection (DAD) is set at 198–205 nm for weak UV absorption for ginseng saponin 
analysis [26, 27]. 
 
In the present study polydimethylsiloxane (PDMS) 100uM fibre was used to separate and identify 
essential oil volatile components, such as the five main components in ginger consisting of 
ĐaŵpheŶe, α-phellaŶdƌeŶe, β-phellandrene, camphor and zingiberene, by SPME–GC–MS analysis 
[28,29].  
 
3.3     Coffee herbal compounds extraction procedure  
3.3.1      Information on instruments and reagents  
1. HPLC: HP Agilent series 1100 DAD system 
2. GC: HP 6890 series GC system 
3. MS: HP 5973 Mass Selective Detector 
4. Fluorimetry: HORIBA Floromax-4 Spectrofluorometer 
5. All coffee and herbs were purchased as food samples fas commercial products, which means 
that these companies are responsible for quality control, evaluating the safety and their 
products ingredients are stable. [Table 3.1] 
Product Content Species  Storage 
condition 
Expiry 
date 
Brand Product code 
(Lot #) 
Roast 
Coffee 
250g 
(per bag) 
Arabica  чϯϬ°C 08/2017 Giancarlo 
coffee 
- 
Liquorice 425mg Glycyrrhiza чϯϬ°C 11/2017 Natures 17036 
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Root (per capsule) glabra Sunshine 
Liquorice 
Root 
250mg/ml 
(in alcohol) 
Glycyrrhiza 
glabra 
чϯϬ°C 07/2020 Eclectic 
Institute 
31382C 
Ginseng 
Root 
100g 
(per bottle) 
Panax 
quinquefolius L. 
чϯϬ°C  01/2017 Naturex GA505003 
Ginseng 
Root  
200mg 
(per capsule) 
Panax  
ginseng 
чϯϬ°C 01/2018 Biovea 5010641 
Ginger  
Dry root 
250mg 
(per capsule) 
Ginger чϯϬ°C 02/2018 Biovea 5022161 
Ginger 
fresh root 
50g Ginger чϯϬ°C Fresh use  Supermarket 
(Woolworths)  
- 
Table 3.1 Coffee and herbs products information list   
 
3.3.2       Mode 1: Comparison of beverages with varying ratios of herbs, via HPLC and GC/MS  
All herbs were stored separately in with well-closed containers with protection from light, the 
laboratory temperature was around 20oC with low humidity.  All herbal materials, coffee bean, 
liquorice and ginseng were ground into powder form (size <2mm) and fresh ginger root was 
prepared by cutting into small pieces (size <4mm). The coffee herbal (100mg) mixtures were 
transferred to a vial with 2 mL of MQ water, with the coffee and herbal ratios as shown in Table 3.2. 
The mixtures were well shaken and allowed to stand for 1 hour in a heat block at 90-100°C in sealed 
vials. All samples were passed through a filtration membrane (0.45um) and the content of caffeine, 
trigonelline, Rb1 and GA were determined by HPLC-DAD. For camphene, the SPME fiber was 
inserted into the vials to obtain coffee herbal beverage aroma for 15min.  
 
 Sample  
(100mg) 
    Coffee       Ginseng         Ginger   Liquorice 
       1   10%(10mg)    20% (20mg)     30%(30mg)   40% (40mg) 
       2   20%(20mg)    10% (10mg)     40%(40mg)   30% (30mg) 
       3   30%(30mg)    40% (40mg)     10%(10mg)   20% (20mg) 
       4   40%(40mg)    30% (30mg)     20%(20mg)   10% (10mg) 
 Table 3.2 Coffee and Herbal Mixture Ingredients and Ratio lists  
 
67 | P a g e  
 
 
3.3.3         Mode 2: Comparison of different extraction methods for the coffee herbal beverage via 
HPLC  
For the microwave oven extraction procedure, the total mixtures of coffee and herb weight was 2g 
and made up to a volume of 200 ml, which covered the sample powder thoroughly in the ceramic 
cups.  The series of beverage samples were put into the microwave cavity, and then heated by 
microwave irradiation (0.5 min, 1min and 1.5min). The sample solutions were then transferred to 
the 15ml flasks every 30 second and all samples were stoƌed at − 20 °C until HPLC analysis was 
performed. 
 
For Soxhlet extraction, the ratios of coffee herbal samples (2 g) were weighed into the thimble. The 
water solvent was made up to a volume of 200 ml. The Soxhlet extraction was performed by gentle 
boiling for 8 hours, then the sample solution was collected in a 15ml volumetric flask.  All samples 
were stored at − 20 °C until HPLC analysis. 
 
For the percolation extraction, coffee and herbal sample were prepared from a 2g ratio mixture 
made up to a volume of 200mL, using a filter coffee machine. The extraction took around 5 min at 
90 °C. The coffee herbal beverage samples were collected and transferred to 15mL volumetric flask 
and stoƌed at − 20 °C till HPLC-DAD analysis.  
 
After all collections, the samples were well shaken in the flask. After shaking,  the supernatant was 
passed through a filtration membrane (0.45um) and the concentrations of caffeine, trigonelline and 
Rb1 and GA were determined by HPLC-DAD. 
 
3.4     The analysis methods of coffee-herbal beverage 
3.4.1     HPLC protocol for coffee and Liquorice [30] 
The HPLC protocol utilized measures the concentration of key coffee and liquorice constituents in 
coffee-herbal beverage including caffeine, trigonelline and glycyrrhizic acid (GA). The mobile phases 
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constituted 4.1% Acetic Acid MQ water and methanol.  Agilent C18 reverse-phase column (150 × 4.6 
ŵŵ; ϱμŵͿ ǁas used and isocratic separation of 28% methanol within 1.5 min, then a linear gradient 
of 28–95% methanol for next 10 min, post run 3 min at last. Separations were carried out at room 
temperature with a flow rate of 2mL/min. The PAD detector was used in the range 200–320nm, and 
quantitative analysis was performed at 254nm (GA), 266nm (trigonelline) and 275nm (caffeine). 
3.4.2     HPLC protocol for ginseng compounds [31] 
The HPLC protocol was used to measure the concentration of Rb1 in the coffee herbal beverage. The 
mobile phases constituted 0.001% formic acid MQ water and acetonitrile (ACN). Agilent C18 
reversed-phase ĐoluŵŶ ;ϭϱϬ × ϰ.ϲ ŵŵ; ϱμŵͿ ǁas used aŶd isoĐƌatiĐ sepaƌatioŶ of Ϯϲ% ACN ǁithiŶ ϴ 
min, then a linear gradient of 26-33% ACN at 10min, 33-45% ACN runs 35 min at last. Separations 
were carried out at 35 oC with a flow rate of 0.8 mL/min. The PAD detector was operated in the 
range 200–320nm, and quantitative analysis was performed at 203nm (Rb1). 
3.4.3     GC/MS analysis of coffee-herbal beverage
 [32] 
Extraction temperature and time are critical parameters in the SPME-GC/MS process. SPME of 
coffee herbal beverage was achieved with a 100uM polydimethylsiloxane (PDMS) coating fiber from 
Supelco at 90-100°C for 15 min. After the adsorption step, the fibre was transferred into GC injector 
in which the analysts were thermally desorbed at 250°C and kept in the hot GC injection spot for 5 
min before removal to obtain complete desorption. GC/MS column oven temperature 40 °C for 3 
min, then programmed at a rate of 12 °C/min to 180 °C, kept at 180 °C for 5 min, and finally ramped 
at a rate of 40 °C/min to 250 °C and kept for 2 min, He carrier gas at 1mL/min. Before use, the fiber 
ǁas ĐoŶditioŶed aĐĐoƌdiŶg to the supplieƌ͛s iŶstƌuctions. 
3.4.4     Analytical standards information 
Analytical Standards of sufficient purity, stability and homogeneity were utilized to prepare the 
calibration curve [Table3.3]. We obtained compounds from Sigma-Aldrich, who provided a 
certificate of analysis (ISO system) for all analytical standards [25]. These standards can achieve the 
accuracy and precision in the analytical results for qualitative and quantitative tests. Most standards 
are of analytical grade except caffeine (шϵϵ.0%) and glycyrrhizic acid (шϳϬ%). During the preliminary 
stage the coffee herbal beverage contents were not fixed; these should be developed for the 
process using, for example, published data and the feedback from human sensory measurement. 
Therefore, this grade reached the requirements for evaluation at the beginning stage and in an 
economic way.  
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Product 
code 
Compound Grade Purity 
 
Water Storage 
condition 
Expiry 
date 
Manufacture 
04070 Alkane 
(C8-C20) 
Analytical 
standard 
neat None 4°C 2018 Sigma-
Aldrich 
C0750 Caffeine Reagent Plus шϵϵ.Ϭ% чϬ.ϱϱ 4°C 2018 Sigma-
Aldrich 
T5509 Trigonelline 
hydrochloride 
Analytical 
standard 
neat None  4°C 2018 Sigma-
Aldrich 
G2137 Glycyrrhizic 
acid 
Non supply  шϳϬ% None  4°C  2018 Sigma-
Aldrich 
 442505  Camphene Analytical 
standard 
 шϵϲ% None   4°C 2017 Sigma-
Aldrich 
Y0001347 Ginsenoside    
Rb1 
European 
Pharmacopoeia 
(EP) Reference 
Standard 
 neat None  4°C 2018 Sigma-
Aldrich 
Table 3.3 Standards information list   
Standard compounds were dissolved in methanol, glycyrrhizic acid (GA), caffeine and trigonelline at 
2.0 mg/ml and camphene, Rb1 at 10mg/mL stock solutions then stored at -20°C until use. The 
mixtures of standard compounds including glycyrrhizic acid (GA), caffeine and trigonelline were then 
diluted to 1000ppm with 25% methanol solution, camphene diluted to 1000ppm and 10ppm 
respectively via pure ethanol and Rb1 by 25% ACN to 1000ppm for usage.  
 
3.5   Thioflavin T (ThT) spectroscopic assay materials and methods [33,34] 
Thioflavin T (ThT), is a benzothiazolium salt dye that was first utilized as a fluorescence microscopy 
probe to study amyloid fibril deposits in histological samples. Then, much later it was developed for 
the in vitro spectrophotometric quantification/assay of amyloid fibrils by the detection of the 
fluorescence emission of ThT because the emission intensity was found to correlate with the fibril 
concentration. ThT has become one of the most widely used methods for selectively identifying and 
analysing the formation of amyloid fibrils both in vivo and in vitro.  When it binds to beta-sheet-rich 
structures such as amyloid fibrils, ThT displays enhanced fluorescence and a characteristic blue shift 
in the emission spectrum from approximately 510nm in the free state to 480nm when bound to 
amyloid fibrils. In protein-only solutions, the interaction of ThT with amyloid fibrils is highly specific. 
Neither amorphous aggregates nor soluble proteins in folded, unfolded, or partially folded states 
enhance ThT fluorescence. However, ThT in situ also interacts with other biomolecules such as DNA 
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by intercalating between DNA base pairs and/or by binding to DNA grooves. Some polysaccharides, 
including proteins such as acetylcholinesterase also induce the characteristic ThT fluorescence, 
presumably through binding to structural cavities. These properties reduce its usefulness for the 
analysis of amyloid fibrils in diagnostic histology.  
Hen egg white lysozyme was purchased from Sigma-Aldrich. The protein concentration was 
prepared at 50mg/ml then adjusted pH to 2 using aqueous HCl and an aliquot of 330ul was added to 
the 1.5ml tube. All test compounds were dissolved in the MQ water including caffeine (10mg/ml), 
trigonelline (10mg/ml), Vitamin B1 (10mg/ml) and caffeic acid (0.5mg/ml). These drugs (330ul) were 
mixed in the protein tube separately and change pH to 2.  All tubes were heated in the heat block 
under 50 °C for 24 hours, 48 hours, 72 hours, 96 hours, 120 hours, 144 hours and 168 hours and the 
fluorescence intensity changes can be measured daily.     
 
Thioflavin T was purchased from Sigma-Aldrich. ThT (1 mg),  dissolved in 1.25 mL phosphate saline 
buffer (PBS, 10mM phosphate, 150mM NaCl, pH 7.0) and kept in the dark at 4 °C. The stock solution 
was then diluted 50 times in the PBS buffer before daily usage. The diluted ThT fluorescence 
intensity was measured at 440 nm (slit width 5 nm) excitation and emission measured at  at 482 nm 
(slit width 10 nm). All test tubes were classified into blank (base line), negative control (untreated 
protein solution), positive control (treated protein solution), caffeine protein group (5mg/mL), 
trigonelline protein group (5mg/ml), Vitamin B1 protein group (5 mg/mL) and caffeic acid protein 
group (0.25 mg/ml).  5 µL of each solution was added to the ThT solution cuvette (about 1.5mL), 
stirred for 1 min then the fluorescence intensity was measured. The measured fluorescence intensity 
increase at 482 nm indicated the presence of aggregated protein accumulation in the solution.  
 
3.6    The analysis of herbal-coffee beverages  
 
3.6.1   Validation of the HPLC assay  
 
The coffee herbal beverage analysis method was validated by the HPLC chromatogram of caffeine, 
trigonelline, GA and Rb1 at 275nm, 266nm, 254nm and 203nm. [Fig.3.1, Fig.3.2]. Calibration curves 
for all the components were obtained in 4-6 independent days using five batches of prepared 
calibration standards containing 20, 40, 60, 80 and 100ppm. The slopes of the standard calibration 
curves of the four compounds showed a good fit and for all least squares analyses; the R2 values 
were greater than 0.999. The Limit of Detection (LOD) was estimated by considering a signal to noise 
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ratio (s/n) of 3:1. The the range of these LODs were around 3-4ppm except for GA of liquorice. The 
results, calibration curves and linear ranges, together with the LOD values, are summarized in 
Table3.4 and Fig.3.3. The percentage relative standard deviations (RSD%) and Mean Recovery 
against 3 nominal concentrations (40ppm, 60ppm and 80ppm) were calculated in order to evaluate 
precision (repeatability) and demonstrate the accuracy of the method during days, which RSD% 
values of intra-day were less than 10% except GA of liquorice at the low concentration level 
(20ppm), and the corresponding Mean Recovery values range were between 99.2% and 102.5%. The 
RSD% and Mean Recovery are presented in Table 3.5. The results that the values noted above were 
acceptable precision and accuracy, although the repeatability intra-days of this measurement 
deteriorated at 20ppm of GA, the methods are still satisfactory. 
 
 
 
 
 
 
 
Fig.3.1 HPLC chromatogram of a standard solution of Tigonelline, Caffeine and Glycyrrhizic acid (GA) 
 
Caffeine 
Trigonelline 
GA 
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Fig.3.2 HPLC chromatogram of standard solution of Ginsenoside Rb1 
 
Table 3.4 Regression equations and detection limits of components determined for 
the presented  HPLC assay 
Components Calibration Curves Linear Ranger (ppm) R
2
 Detection Limit (ppm) 
Caffeine y=30.181x+10.882 20-100 0.9997 3.334 
Trigonelline y=14.856x-0.8158 20-100 0.9994 4.116 
GA y=5.5154x+16.704 20-100 0.9998 12.313 
Rb1 y=3.6325+3.6498 20-100 0.9992 3.674 
Detection of Limit is defined as the concentration where the signal-to-noise ratio is ϯ; Ŷшϰ 
 
 
Fig.3.3 Calibration curves of Tigonelline, Caffeine and Glycyrrhizic acid (GA) and Ginsenoside Rb1 the 
regression equations of the four compounds with R2 > Ϭ.ϵϵϵ, ƌespeĐtiǀelǇ. ;ŶшϰͿ 
  
Caffeine 
y = 30.181x + 10.882 
R² = 0.9997 
Trigonelline 
y = 14.856x - 0.8158 
R² = 0.9994 
GA 
y = 5.5154x + 16.704 
R² = 0.9998 
Rb1 
y = 3.6325x + 3.6498 
R² = 0.9992 
0
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Standards of Caffeine, Trigonelline, GA and Rb1 callibration curves 
m
A
U
 
Standards Concentrations (ppm) 
Rb
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Table 3.5 Intra-day  precision and accuracy  for the HPLC assay of four 
components  
Nominal  
Concentration (ppm) 
Measured  
Concentration R.S.D (%) Mean Recovery (%) 
Caffeine 
   40 39.609±0.494 1.247 99.023 
60 60.122±0.633 1.206 100.202 
80 79.208±1.247 1.574 99.01 
Trigonelline 
   40 39.555±1.602 4.051 98.887 
60 59.915±3.014 5.036 99.859 
80 78.963±4.883 6.184 98.703 
GA 
   40 39.709±5.056 12.733 99.273 
60 60.695±6.021 9.449 101.158 
80 79.565±7.028 8.832 99.456 
Rb1 
   40 39.162±1.585 4.046 97.905 
60 61.473±2.357 3.835 102.456 
80 80.109±1.756 2.192 100.13 
N=4; R.S.D: Relative Standard Derivation; Mean value (± standard deviation) 
 
 
 
3.6.2    Validation of the GC/MS assay 
3.6.2.1   Method validation by Kováts index (I). 
Kovats indices are used to measure/characterize compounds under isothermal column condition, 
Where NX is the unknown analyte, Nn and N(n+1) are the number of carbon atoms of the reference 
n-alkaŶes ǁhiĐh ďƌaĐket the ƌeteŶtioŶ tiŵe of the uŶkŶoǁŶ aŶalǇsts, t͛ aƌe the ƌeteŶtioŶ tiŵe of the 
analysts or references of n-alkanes. Here the n-alkanes retention time NC8 was set as t͛NŶ, ǁhile 
aŶotheƌ t͛NCϮϬ as t͛N;Ŷ+ϭͿ. Values were calculated via the Kováts index (I) calculator. 
 
 
From Fig.3.4, n-alkanes elution peaks were free of noise interference. Under the same three day 
conditions, the n-alkanes (C8-C20) Kováts Indices relative standard deviation (RSD) values are <0.5%. 
The method precision and accuracy is considered to be acceptable. The n-alkanes (C8-C20) mass 
match quality received 95% on average [Table 3.6; Table 3.7]. The absorption amounts of 
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monoterpenoid from coffee-ginger beverages relate to the absorption period. The amounts of 
caffeine were obtained in 10min by the conditions, [Fig.3.5] however caffeine cannot be detected 
less than 2min or 5min. The essential oils from ginger and caffeine Kováts Indices relative standard 
deviation (RSD) values are also less than 0.5% after test three times and the analytes mass match 
quality were 95% on average.  
Table 3.6.  Comparison of three times n-alkanes(C8-C20) Kovats Indices and the percent of quality  
Mass Match. 
 Fig. 3.4 GC chromatogram of standard of n-alkanes(C8-C20) 
 
 
 
Standard  Kováts Indices Mass  
 
Compounds Test1 Test 2 Test 3 
Match 
(%) 
 Octane  C8H18 * * * 96 
 Nonane C9H20 931 930 931 95 
 Decane C10H22 1047 1047 1048 94 
 Undecane C11H24 1152 1151 1152 95 
 Dodecane C12H26 1247 1246 1248 95 
 Tridecane  C13H28 1335 1335 1336 95 
 Tetradecane  C14H30 1418 1417 1419 93 
 Pentadecane  C15H32 1506 1503 1505 95 
 Hexadecane  C16H34 1619 1611 1613 97 
 Heptadecane  C17H36 1768 1758 1758 97 
 Octadecane  C18H38 1882 1880 1883 98 
 Nonadecane  C19H40 1944 1943 1944 97 
 Eicosane  C20H22 * * * 99 
 
C8 
C10 
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Table 3.7 Comparison of three times monoterpenoid and caffeine Kováts Indices and the percent of 
quality mass match. *was not detected 
 
  Fig.3.5 GC chromatogram of coffee-ginger beverage 
 
3.6.2.2    Camphene calibration curves 
The coffee herbal beverage quantitative analysis of camphene from ginger method was validated by 
SPME-GC/MS chromatography. The linear ranger of the calibration curves for the GC-MS analysis 
were 20-60 ppm(R2 =0.9686) and 0.2-5ppm(R2 =0.9998)[Fig.3.6 and Fig.3.7]; The limit of detection 
(LOD) was measured using a a signal to noise ratio (s/n) of 3:1 and were 7.100 ppm and 0.055ppm, 
using 20ppm and 0.2ppm camphene standard solution respectively.[Table 3.8] The results, shown in 
Table 3.9, are expressed as the percentage relative standard deviations (RSD%) and Mean Recovery 
against 3 nominal concentration (20, 40, 60ppm; or 0.2, 1, 5ppm) in both methods. The typical 
precision range (RSD%) lies between 2 and 17%, which is acceptable considering the very low 
concentrations of the analyte. The accuracy data, represented as mean recovery (%), suggested the 
recovery was 91–112% with a mean of 100.364% and a RSD% of 8.382%. 
 
Kováts Indices s  
 Compounds 
Test1 Test 2 Test 3 
Match 
(%) 
 Pinene<Alpha-> C10H16 975 976 976 96 
 Camphene   C10H16 996 997 997 97 
 Myrcene  C10H16 1036 1036 1037 96 
 Limonene  C10H16 1083 1084 1084 97 
 Cineole <1,8->   C10H18O 1088 1089 1089 91 
  Linalool   C10H18O 1152 1153 1153 90 
  Neral  C10H16O 1283 1285 1285 95 
 Geranial C10H16O 1309 1310 1311 95 
 Zingiberene <Alpha->C15H24 * 1507 1505 95 
 Caffeine  C8H10N4O2 1910 1910 * 95 
 
C17 
Camphene 
Caffeine 
Geranial 
Cineole 
Pinene 
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Table 3.8 Regression equations and detection limits of components determined for the 
presented GC/MS assay 
 
Components Calibration Curves 
Linear Ranger  
(ppm) R
2
 
Detection 
Limit (ppm) 
 Camphene y=7×10
6
x+121186 0.2-5 0.9998 0.055 
 Camphene y=5×10
6
x+2×10
7
 20-60 0.9686 7.1 
 Detection of Limit is defined as the concentration when the signal-to-noise ratio is 3 
 
 
  
Fig.3.6 Calibration curves of Camphene in the both the concentration ranges with R2 > 0.96 
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Table 3.9  Intra-day precision for the GC/MS assay of ginger component (n=4) 
nominal  
concentration (ppm) 
Measured  
concentration R.S.D (%) 
Mean  
Recovery (%) 
  Camphene       
  0.2 0.216±0.018 8.489 108.014 
  1 0.910±0.020 2.272 91.003 
  5 4.670±0.425 9.303 93.436 
  Camphene 
     20 22.403±2.366 10.564 112.014 
  40 38.296±1.552 3.016 95.741 
  60 61.188±10.546 17.236 101.98 
  R.S.D: Relative Standard Derivation; Mean value (± standard deviation) 
 
 
 
Fig.3.7 GC/MS chromatogram of standards solution of Camphene and Caffeine 
3.6.3   Mode 1: Compounds concentration in coffee-herbal beverage  
In order to evaluate the applicability of the developed method, coffee-herbal beverage samples 
were analysed, with ingredients content from 10% to 40%. Caffeine, trigonelline, GA and Rb1 peak 
areas correspond to the concentration by the use of external calibration curves. The contents of 
caffeine, trigonelline, GA and Rb1 in these samples are shown in Table 3.10, Table 3.11 and Table 
3.12. Fig.3.8 and Fig.3.9 shows typical chromatograms that caffeine, trigonelline, GA and Rb1 were 
separated in the beverage. Caffeine values ranged from 60.90 to 211.05 mg in a 350mL coffee cup. 
Trigonelline contents in a 350mL cup are from 84.7mg to 170.8mg. Therefore, the contents of the 
GA and Rb1 can be determined as well.  
Various herbal source and extract methods lead to the contents variability. Clearly, the GA peak 
areas in the chromatograms compare Liquorice Liquid extract (LL) with Liquorice Powder (LP), 
indicating the greater mass GA obtained in Liquorice Liquid extract (LL). The results of the GA 
analysis assays demonstrate that the amount is almost 2-3 fold greater than Liquorice Powder (LP) in 
Camphene 
Caffeine 
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coffee herbal beverage (350mL). Additionally, The GA concentration is more reproducible in 
liquorice liquid extract (LL). The Rb1 assay results indicate that the amounts of the main ginsenosides 
Rb1 in the extracts of American ginseng (AG) appears to be greater than that present in undefined 
ginseng (UG), which are 3-4 times in coffee herbal beverage (350mL).  
Table 3.10  Amounts peak area  and the concentration of Caffeine, Trigonelline in coffee-herbal beverage  (n=4) 
Beverage Compounds 10% Coffee                            20% Coffee         30% Coffee                          40% Coffee 
(100mg mixture in 2mL) Caffeine Trigonelline Caffeine Trigonelline     Caffeine Trigonelline Caffeine Trigonelline 
Peak Area 
(mAU) 
539.012± 
68.454 
357.964± 
54.218 
973.390± 
65.820 
536.507± 
136.533 
1446.192± 
108.60 
671.826 
±84.73 
1830.223 
±105.92 
836.880 
±238.7 
Con. In Analysis 
(1:10) (ppm) 
17.499± 
2.268 
24.150± 
3.650 
31.891± 
2.181 
36.169± 
9.910 
47.556± 
3.6 
45.277 
±5.706 
60.281 
±3.510 
48.767 
±6.078 
Con. In Beverage(mg/mL) 0.174 0.242 0.319 0.362 0.476 0.453 0.603 0.488 
Contents in 350ml cup(mg) 60.900 84.700 111.650 126.700 166.600 158.550 211.050 170.800 
Mean ± standard deviation. 
Table 3.11 Comparison of peak area  and the concentration of GA from liquorice Powder(LP), GA from 
liquorice liquid extract(LL) in coffee-herbal beverage  (n=3)   
Beverage Compounds 10% Liquorice 20% Liquorice         30% Liquorice 40% Liquorice 
(100mg mixture in 2mL) GA(LP)1:5 GA(LL)1:10 GA(LP)1:5 GA(LL)1:10 GA(LP)1:5 GA(LL)1:10 GA(LP)1:5 GA(LL)1:10) 
Peak Area 
(mAU) 
88.694± 
70.264 
146.541 
±32.621 
194.040 
±98.032 
249.470 
±33.588 
379.820 
±148.740 
404.113 
±17.131 
493.410 
±164.152 
526.016 
±10.133 
Con. In Analysis  
(ppm) 
13.053± 
12.740 
23.541 
±5.915 
32.153 
±17.774 
42.203 
±6.090 
65.837 
±26.968 
70.241 
±3.106 
86.432 
±29.762 
92.344 
±1.837 
Con. In Beverage(mg/mL) 0.065 0.235 0.16 0.422 0.329 0.702 0.432 0.923 
Contents in 350ml cup(mg) 22.750 82.250 56.000 147.700 115.150 245.700 151.200 323.050 
Mean ± standard deviation 
   Table 3.12 Comparison of peak area and the concentration of Rb1 from American ginseng(AG), Rb1 from  
unidentified ginseng source(UG) in coffee-herbal  beverage  (n=3) 
Beverage Compounds 10% ginseng                       20%ginseng                            30% ginseng     40% ginseng 
(100mg mixture in 2mL) 
Rb1(UG) 
1:5 
Rb1(AG) 
1:10 
Rb1(UG) 
1:5 
Rb1(AG) 
1:10 
  Rb1(UG) 
  1:5 
    Rb1(AG) 
    1:10 
Rb1(UG) 
1:5 
Rb1(AG) 
1:10 
Peak Area 
(mAU) 
50.939 
±10.684 
91.124 
±21.164 
    98.107 
    ±6.935 
  181.080 
  ±23.861 
  108.114 
  ±31.436 
   241.621 
   ±46.310 
     208.138 
     ±35.923 
   312.918 
   ±33.608 
Con. In Analysis  
(ppm) 
13.018 
±2.941 
24.081 
±5.826 
    26.003 
    ±1.909 
  48.845 
  ±6.569 
   28.758 
   ±8.654 
   65.512 
   ±12.749 
     56.294 
     ±9.889 
   85.139 
   ±9.252 
Con. In Beverage(mg/mL) 0.065 0.241     0.13   0.488    0.144     0.655       0.281    0.851 
mean ± standard deviation 
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Fig.3.8 Coffee herbal beverage sample HPLC chromatogram of trigonelline, caffeine and GA and 
dilution (1:10) with 25% methanol. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.9 Coffee herbal beverage sample HPLC chromatogram of Rb1(AG) and dilution (1:10) with 25% 
Acetonitrile 
 
3.6.4 Camphene concentration  
 
Camphene concentrations in the coffee herbal beverage samples [Fig.3.10] were calculated from the 
peak area with both standard calibration curves linear ranges defined. The camphene concentration 
in fresh ginger (FG) was much greater, especially (30% and 40% ratio) in coffee herbal beverage 
[Table.3.13] and were 16-26 fold higher than Ginger Capsule (GC). Therefore, Camphene is a highly 
volatile compound in Fresh Ginger (FG) and it has been mentioned that Ginger Capsule (GC) should 
be taken to account on rapid loss of the analyst.   
Caffeine 
GA Trigonelline 
Rb1 
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Table 3.13 Comparison of peak area and the concentration of camphene from fresh ginger(FG), and from  
ginger capsule(GC) in coffee-heƌďal  ďeǀeƌage  ;ŶшϯͿ 
Beverage 10% ginger 20% ginger 30% ginger 40% ginger 
Compounds FG GC FG GC FG GC FG GC 
Peak Area 
(Abundance) 
4.197×10
7
 
±1.650×10
7
 
2.490×10
6
 
±7.029×10
5
 
2.224×10
7
 
±6.765×10
6
 
3.241×10
6
 
±5.925×10
5
 
1.533×10
8
 
±6.035×10
7
 
7.227×10
6
 
±2.158×10
6
 
1.808×10
8
 
±1.075×10
8
 
1.375×10
7
 
±3.099×10
6
 
Con. In Analysis 
 (ppm) 
5.980 
±2.358 
 0.339 
±0.100 
3.159 
±0.966 
0.445 
±0.085 
26.657 
±12.070 
1.015 
±0.308 
32.158 
±21.490 
1.947 
±0.443 
Contents in  
350ml cup(mg) 2.093 0.118 1.105 0.155 9.329 0.355 11.255 0.681 
Mean ± standard deviation. 
 
  
 
Fig.3.10 Coffee herbal beverage sample GC/MS chromatogram of camphene and caffeine 
 
3.6.5 Mode 2: Herbal-Coffee beverage extraction methods 
 
Obviously, these compounds including caffeine, trigonelline, Rb1 and GA from coffee herbal 
functional beverage, had a good yield obtained via pure water as the extraction solvent in 
microwave-assisted, percolation (coffee machine) and Soxhlet extraction [Fig.3.11]. The recipe of 
each component used a 25% ratio in the beverage, that is 0.5 each in 2g composites. Caffeine 
(alkaloids), trigonelline (hydrochloride salt), glycyrrhizic acid (saponin) and ginsenoside Rb1 
(protopanaxadiol and dammarane family) are all extracted via the excellent polar solvent water. It is 
accepted coffee indigents are extracted via microwave heating and coffee machines and, especially, 
Rb1 and GA from Liquorice and Radix ginseng are released at low temperature (90-100°C) and in a 
short time (1min). However, there will be a shortage for Rb1 in the coffee machine extract in this 
case. The coffee machine requires slow passage of a solvent through fine particles. Therefore, the 
Camphene 
Caffeine 
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sample mixture must be merged properly so that the solvent contacts these particles equally, which 
sometimes is determined by the machine extract design. As Rb1 extraction can be seen in the 
Soxhlet case, the longer the extracting time, the lower the yield. This phenomenon could be result 
from the hydrolysis of one or two sugar from ginseng saponin (containing 4 carbohydrates) with long 
heating time.  On the other hand, because of water as the extract solvent, it carries along with lots of 
other plant components such as sugar, starches proteins with longer heating time, that could adsorb 
the effective constituents extracted. We considered that water as solvent and the microwave 
heating and percolation (coffee machine) extraction can be used to produce coffee herbal functional 
beverage. Hence Fig 3.11 shows that, except for Rb1, similar amounts of the compounds are 
extracted by each method (the mean value for each method is within confidence intervals of the 
other methods ie. they all overlap). 
 
Fig.3.11 The coffee herbal beverage compounds concentration measurement via various extraction 
methods (with 95% confidence intervals) 
The microwave effect of coffee herbal functional beverage amount on the extraction efficiency was 
also studied. Samples with the ratio of 75% coffee and 25% herbs the total mass 2 g in 200 ml water 
were analysed by HPLC-DAD with these collected at 0.5 min, 1min and 1.5min. The above figure 
shows the concentration of the four compounds (caffeine, trigonelline, GA and Rb1) in the functional 
beverage. As seen from the above Figure 3.11, increasing the extraction time (from 0.5 min to 1.5 
min) did not significantly enhance the extracted amount of the analysts in the beverage and the 
extraction balance was achieved. Therefore, the mid extraction time for coffee herbal compounds 
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with the microwave oven extraction set at 1 min. This extraction time shows that the maximum of 
compounds are extracted and when preparing a coffee beverage with microwave heating, 1 min 
would give a good temperature for herbal-coffee preparation [Fig.3.12].  
 
Fig.3.12 The amount of compounds extraction via microwave heating 
 
3.7   ThT assay measurements 
 
Hen egg white lysozyme amyloid protein can spontaneously assemble into protein fibrils under the 
experimental acid conditions of the in vitro studies. Green tea polyphenols [35], curcumin [36], 
myricetin [37], have been reported as effective inhibitors of the fibrillogenesis of hen egg white 
lysozyme (HEWL). A report demonstrated that curcumin can inhibit the aggregation and formation 
of amyloid fibrillation of HEWL at pH 2.0 in a dose dependent manner [36]. Importantly, evidence 
indicates that amyloid fibril inhibition of HEWL by phenolic compounds involves formation of 
quinoprotein interactions [38]. HEWL was incubated with or without these compounds and ThT 
fluorescence intensity increased in the presence of protein fibrils which were measured every 24 
hours for each group. We monitored the temperature-dependence of ThT fluorescence intensity to 
examine the ability of natural compounds to inhibit the aggregation of protein such as caffeine, 
trigonelline and caffeic acid from coffee and Vitamin B1 as a resource from daily food. We will utilize 
semi-ƋuaŶtitatiǀe aŶalǇsis to ŵake the deĐisioŶ ͚͛Ǉes oƌ Ŷo͛͛ to ĐoŶfiƌŵ the possiďilitǇ foƌ Ŷatuƌal 
compounds to inhibit protein fibrillation. Another purpose of the experiment was to ensure 
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measuring conditions including incubation temperature, test time point, drug concentration as 
optimal and the reproducibility of all these parameters is important for further quantitative 
assessment of more compounds at next stage.  All ThT Fluorescence intensity normalized to the 
blank and was plotted as a function of time for 5mg/ml or 0.25 mg/mL at 50 oC in PBS (pH=2) 
without or with herbs. The normalization ThT fluorescence intensity incubated without herb 
constituents (positive control) increased rapidly after the equilibration period (72 hours), which 
demonstrated protein fibril formation.  Caffeine, caffeic acid and vitamin B1, all led to a dramatically 
decreased ThT fluorescence intensity normalization [Fig. 3.13], which was individually compared to a 
positive control. This suggests that the compounds could affect the neuro-protection against protein 
aggregation formation and this requires further investigation of  the efficient concentration-
dependent inhibition. However, trigonelline, at concentrations up to 5mg/mL, had little effect on the 
ThT fluorescence response and only a small decrease and this also needs further confirmation. The 
negative control is untreated/blank protein solution as a measurement base line, which the protein 
solution did not change the pH when heated. In addition, all test coefficient of determination (R2) 
should improve further by more replicate test times during quantitative analysis.  
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Fig.3.13 Semi-quantitative curve of protein fibrillation in the presence or absence of different nature 
compounds. The values are means ± SD, n = 3. 
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4 
 
Herbal-coffee beverage sensory analysis  
 
Chapters 2 and 3 described the herbal-coffee beverage targeted bioactive compounds selection and 
analysis. Chapter 4 describes the assessment of herbal-coffee sensory human perceptions of 
potential/desirable/continuous consumption to sustain effective prevention against dementia. 
 
4.1      Functional beverage sensory measurement  
 
The European Functional Food Science Commission defined functional foods (which include 
beverages) as:"...satisfactorily demonstrate to affect beneficially one or more target functions in the 
body, beyond adequate nutritional effects, in a way which is relevant to either an improved state of 
health and well-being and/or reduction of risk of disease." Functional foods became popular for 
consumers who are seeking specific health effects to keep fit and feel good regardless as to whether 
the food has been modified in some fashion [1]. Several herbs claim medicinal benefits due to their 
preventative properties such as anti-inflammation, anti-oxidants that also includes the perception of 
taste, aroma and the oral perception of texture [2,3,4].  The sensory properties determine peoples͛ 
selection and how much they consume [5]. The bioactives from natural herbs not only affect 
function beverage performance but also the drinking habits and long term consumption. However, 
undesirable flavours in functional beverages may decrease the sensory acceptance and eventually 
may discourage continued consumption if perceived as bitter, acrid, astringent or salty off flavours. 
The human study is designed to review results from investigation of human preferences and the 
sensory perceptions to the new functional beverages that were sampled. Functional beverages of 
oƌaŶge flaǀouƌed ďaƌelǇ β-glucan was assessed by 105 members of a panel through sensory 
evaluation including sweetness, sourness, orange flavour and thickness to estimate overall market 
acceptability [6].    
 
4.2      Effect of herbal-coffee beverage constituents on sensory perception 
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Aroma is also central to a pleasurable eating/drinking experience and is one of the most labile 
components of food, coffee is an outstanding example. There are more than eight hundred volatile 
compounds that have been identified in coffee, many of which have been demonstrated to 
contribute to its aroma. The aroma profile of coffee is composed of the following notes: 
sweet/caramel-like, earthy, roasty, smoky, fruity and spicy [7]. Liquorice has a sweet flavour and is a 
diet multi-therapy herb. Glycyrrhizinic acid, a chief sweet-tasting constituent extract from liquorice 
root is about 50 times as sweet as cane sugar [8].  This product has been approved in the United 
States for a wide range of applications [9]. Some applications claim liquorice root extract can be used 
to make foamy food, to enhance foam stability or to impart aroma. Ginseng functional products 
have been largely limited to functional beverages because of the undesirable sensory properties of 
ginseng such as earthy, wood, astringent and bitter [10]. Ginger has been used as a spice for over 
2000 years and has pleasurable aromas such as sweety, warm and also a pungency flavour.  
 
4.3      Sensory assessment (9-point hedonic scale) applications in food science 
 
Taste provides important sensory information of beverages and it also impacts hedonics, pleasure 
and displeasure. Hedonics reflect the immediate experience or anticipation of pleasure from the 
sensory stimulation of eating a food including taste, smell, and texture, [11] and promotes 
behaviours of long term usage associated with the enhanced acceptance [12]. 
 
In human taste panel studies, subjects assess the taste quality and intensity such as overall intensity, 
sweet, sour, salty, bitter, metallic, cooling, spicy, anaesthetic, astringent, irritating and other tastes 
[13]. Twenty five assessors participated in sensory analysis of coffee colour, aroma and flavour 
evaluation using a hedonic scale to determine the degree of likeness or not of the coffee samples 
[14]. Sixty eight customers participated in a hedonic value characteristic of wild blueberry–soy 
beverages by 9-point hedonic scale comprising colour, flavour, viscosity, customer attitudes and 
overall acceptability [15]. Twelve persons using the sip-and-spit method, assessed the individual 
theaflavins for the overall astringency of black tea [16].  
 
Therefore, the ĐoŶsuŵeƌs͛ seŶsoƌǇ peƌĐeptioŶ can be recorded through a 9-point hedonic scale 
(sensory preferable level). And the sensory assessment form can be used to qualify or quantify the 
paƌtiĐipaŶt͛s hedoŶiĐ faĐtoƌs oƌ leǀels of distƌess. 
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4.4      Participant recruitment method 
 
Any healthy males and females aged 18-70 years old, who like to drink coffee and are free of 
allergies to herbs were potential participants in a sensory evaluation of coffee-herbal beverages at 
RMIT University. The project was approved by the RMIT Human Research Ethics Committee. Eight 
people were invited to participate in the project. 
 
In the future the herbal beverage will be modified to satisfy the general public. All potential 
participants were randomly selected. A possible way of random participant selection could be using 
a lottery method. In practice, a Random Number Generator produces 2 random number orders 
between the ranges 1 to 5 without duplicating numbers.  
 
4.5       Herbal-coffee beverage preparation 
 
The coffee-herbal samples (ginseng, ginger and liquorice) were boiled with hot water (90-100 
degrees) for 45 min. The concentration used was 100mg of a mixture in 2 mL water. 
The Testing Sample Ingredients are shown below. 
  Sample     Coffee            Ginseng               Ginger              Liquorice 
       1       10% (10mg)     20% (20mg)      30% (30mg)       40% (40mg) 
       2       20% (20mg)    10% (10mg)       40% (40mg)       30% (30mg) 
       3       30% (30mg)    40% (40mg)       10% (10mg)       20% (20mg) 
       4       40% (40mg)    30% (30mg)       20% (20mg)       10% (10mg) 
       0       Water Blank                Blank                  Blank                   Blank 
 
4.6      Herbal-coffee beverage sensory assessment procedure 
 
Participants should follow a few steps when testing the samples. The whole procedure is expected to 
take 30min. The test procedure was a "one off". No photographs or videos were recorded during the 
assessment. 
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Testing procedure 
1. Every participant to mouth rinse with water at the beginning of the study. 
2. The participants receive 5 taste samples about 1-2 ml per cup in 1 to 5 sequence. 
3. These samples are in the mouth for at least three seconds; then the participant can choose to 
swallow or expel sample. 
4. The participants immediately record for each sample, their response to hedonic scale such as 
flavour, tasty, texture. 
5.  Provide voluntary feedback on the coffee-herbal beverage for future modification (optional). 
 
4.7      Sensory measurement protocol  
 
Previously no adverse consequences or clinical reports were found after drinking 1g of the herb-
beverage. But undesirable flavours such as bitterness, astringent, earthy in some of the beverages 
may decrease the sensory perception. This hedonic scale describes an equal number of positive and 
negative categories with intervals of equal size; for example, 1=not at all like, 3=slight like, 
5=moderate like, 7= like very much and 9=extremely likeable [Appendix 1]. 
 
4.8      Hedonic scale statistical analysis  
Every participant tasted samples 1 to 5 once, so these sample items such as colour, sweetness and 
astringent etc., were repeated measurement 8 times by 8 individuals. Then we compared the 
difference of the items between the two sample groups via Paired Tests (the items of sample 1vs 2, 
3, 4, 5; the items of sample 2vs 3, 4, 5; the items of sample 3vs 4, 5; and the items of sample 4vs 5). 
Thus the null and alternative hypotheses are: 
HϬ: μD ч Ϭ ;ŵeaŶ the iteŵ of HedoŶiĐ SĐale iŶ this saŵple is less thaŶ oƌ eƋual to that sample)   
Hϭ: μD > Ϭ;ŵeaŶ the iteŵ of HedoŶiĐ SĐale iŶ this saŵple is gƌeateƌ that saŵpleͿ 
ChoosiŶg a leǀel of sigŶifiĐaŶĐe of α=Ϭ.Ϭϱ aŶd assuŵiŶg that the diffeƌeŶĐes aƌe ŶoƌŵallǇ 
distributed, for an item of n=8, there are n-1=7 degrees of freedom.  
The reasons for assuming that the differences normally distribution: 
1. There are no literature reviews to provide this information with regard to herbal-coffee hedonic 
scale population distribution.  
2. According to the Central Limit Theorem conclusion, if we do not know the specific shape of the 
population distribution more than 30 samples would be selected. However, we want to improve the 
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result accuracy as well as cost effectives of the procedure. This would be the best cost-effective 
method of choice for the small group selection before any valued results obtained.   
The conclusion data will reflect what sensory participant is preferable.  
4.9     Hedonic scale record discussion 
 
A small group of 8 healthy participants (4 males and 4 females) were randomly selected and 
completed the Sensory Analysis Evaluation Form to evaluate the functional beverage flavor 
acceptance and consumption. Overall, there were no significant average or distribution differences 
in hedonic scale ratings between these samples, which could be induced by a small group selection 
as one of reasons. All participants who tasted the beverage perceived the samples (1-4) between 
strong and very strong, and the prepared herb concentrations were perceived as too high. The 
normalized ƌatiŶgs ;Ŷegatiǀe ĐoŶtƌolͿ ƌefeƌ to the Đode of ͞Ϭ͟, pƌoduĐed siŵilaƌ fuŶĐtioŶs eǆĐept the 
sweetness tasty, which needs to be investigated further. The sample 3 and 4 (including 30% and 40% 
coffee), texture (colour) number averages were greater than 30% of sample 1, 2 and had a 
favourable colour of coffee brown [Fig.4.1]. Participants were more likely to enjoy spicy flavour, 
where scale numbers exceeded nearly 40% in sample 1 and 2 containing 30-40% ginger. However, 
ginseng root produced similar earthy scale ratings and modest equivalent associations with the 
content, which also included roast smell sensations [Fig.4.2]. In the oral sensory perceptions, 
participants were skewed toward higher intensities of astringent and bitterness, which indicates we 
must remove astringent compounds such as ginseng, and particularly bitter compounds in coffee 
because these decrease tasty acceptance and enjoyment and subtract from sweet sensory 
perceptions [Fig.4.3]. Through this small group analysis some valuable data was obtained; we 
consider that the elimination of the perceived negative sensory compounds that lead to earthy 
astringent taste perceptions will enhance the perceived acceptable beverage taste including the 
favored roasty and sweetness perceptions for future larger human taste perception studies.     
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Fig.4.1. Texture of Hedonic Scales values in herbal-coffee beverage 
 
 
Fig.4.2. Flavors of Hedonic Scales values in herbal-coffee beverage 
 
 
Fig.4.3. Tasty of Hedonic Scales values in herbal-coffee beverage 
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5 
 
Conclusion and suggestions for further work 
 
 
 
The preceding chapters have illustrated the experimental design, instrumental analysis of coffee 
herbal functional beverages. Sample extraction and analysis can be achieved with convenient 
extraction methods that are compatible with existing HPLC-DAD and GC-MS detection. The 
participant sensory evaluations were measured by a small group (8 people invited) with a 9-point 
hedonic scale.   
 
5.1 Conclusion  
 
The strategy of this research project is focused on the potential prevention and treatment of 
cognitive impairment by recommending the consumption of coffee herbal beverages as early as 
possible in life.  
 
Firstly, epidemiological studies suggest that dietary measures, physical exercise, and mental activity 
may reduce the risk of cognitive impairment and AD in elderly subjects. However, these preventative 
activities are not easy to qualify, quantify and to track their performance. As evidenced by the 
effective constituents of coffee and herbs against the cognitive impairment (presented in Chapter 2) 
they are an emerging area of interest. At the start of this project, we set the selection criteria and 
chose suitable herbs and their constituent bioactives including caffeine, trigonelline, glycyrrhizic acid 
(GA), Rb1 and camphene from coffee, liquorice, ginseng and ginger.  These natural products are 
active against dementia and have an acceptable human safety profile related to the amyloid 
hypothesis, cholinergic hypothesis, inflammatory/oxidative hypothesis, Ca2+ and adenosine receptor 
hypothesis, that contribute to the potential causes that lead to AD.  
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Secondly, the purpose of the project was the analysis of the functional beverage to confirm the 
concentration of the effective constituents that are conveniently extracted into the beverage, which 
enables the analysis of the ingredients to evaluate their protective effects over long term 
consumption (presented in Chapter 3). Water, a polar solvent, safe for the intake of the effective 
constituents in coffee-herbal beverages. The target compounds were measured after the various 
extraction methods such as decoction, percolation (coffee machine), microwave heating, Soxhlet 
and SPME to evaluate if the compounds were effectively extracted by these various techniques. 
After HPLC analysis, we concluded that the constituents (e.g. caffeine, trigonelline, GA and Rb1) 
were released completely at 90-100°C (coffee machine) or 1min (microwave oven) that were much 
better than the high temperature (100°C), or longer extraction times ;шϴ houƌsͿ by Soxhlet 
extraction. In addition, we measured the increasing constituent ratios of the target compounds 
concentration range from 10% to 40% by HPLC and GC/MS from decoction extraction methods. The 
HPLC and GC/MS analysis methods were validated, by parameters including identification, accuracy, 
precision, linearity and acceptable limit of detection. Therefore, the different ratio of the 
components of these target compounds (caffeine, trigonelline, GA, Rb1 and camphene) is available 
for evaluation for future work. We also compared the contents of these compounds from different 
sources. The results indicated that American ginseng extracts contained the highest amount of Rb1 
and fresh ginger containing camphene of ginger oil extracted the most GA.  The result showed a 
promising prospect for quality control of extracting the effective herb constituents to produce a 
coffee herbal functional beverage.  
 
We used in vitro Thioflavin T (ThT) fluorescence assays to confirm that the selected natural products 
have the potential to inhibit β-sheet amyloid protein fibrillation. In vitro measurements of the pure 
natural compounds including caffeine, caffeic acid and vitamin B1, inhibited the amyloid protein of 
HEWL from fibrillation over extended heating times (50°C for 144 hours) in an acidic environment 
(pH=2). Also, a small number of people (8 healthy adult participants) estimated the sensory 
perception of the herbal-coffee beverages. The positive feedback from the participants indicated 
that the sampled herbal-coffee beverages were too ͚͛stƌoŶg͛͛, implying that the effective constituent 
concentration were too high.  In future a balance between neuroprotection and sensory acceptance 
needs to be determined.  This is particularly relevant to ginseng, as it has a characteristic earthy 
astringent perception that strongly influences the taste of herbal-coffee beverages.  
     
5.2      Suggestions for future work 
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We used the in vitro model amyloid protein of HEWL to investigate whether some natural binding 
effects were present in the coffee-herb constituents to inhibit amyloid fibril formation. Future work 
could utilize native or synthetic aŵǇloid β protein or infected cells to assess the rate of inhibition of 
natural products in vitro. The small [8] number of participants in human sensory perception study 
was a limitation of this study and could be extended to a much larger cohort of panel members that 
would more reliably determine the best acceptable herbal-coffee formulations. Future work should 
include post-consumption/intake of the herbal beverages, the analysis of the detection, 
measurement of relevant and specific herbal biomarker metabolites as evidence for their 
benefits/presence, to encourage continuous consumer consumption whilst also providing/imparting 
benefits against dementia.  
In addition, it is important to measure the functional beverage-brain affects in vivo with animal 
model studies in mice or rats, that can be used to monitor the beverage safety and efficiency. Also 
for coffee-herbal beverages safe intake studies, the use of healthy animals would allow the 
investigation and analysis of any affects on various organs extended over months or years.  
Additionally, AD transgenic mice can be used to evaluate the beverage brain protection performance 
and efficacy.   
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Appendix 1 
 
Table.1. Herbal Coffee Beverage Sensory Analysis Evaluation 
This template was used for data collation to help assess the herbal coffee beverage acceptance. 
  Code:                                          Gender:                        Age ranges:         ~40               40~60              60~ 
0=none of above, 1=not at all like, 3=slight like, 5=moderate like, 7= like very much and 9=extremely 
likeable 
Number the items in order of your taste 
Sample 1 2 3 4 5 
 
A  Texture 
Hedonic  Scale 
0,1,3,5,7,9 0,1,3,5,7,9 0,1,3,5,7,9 0,1,3,5,7,9 0,1,3,5,7,9 
 
Colour 
     
B  Odour Flavour      
 
Roasty 
     
 
Spicy 
     
 
Root/Earthy 
     
 
C  Tasty 
     
 
Sweetness 
     
 
Bitterness 
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Astringent 
D Expected cost 
(350ml/bottle) 
~$3                            $3~$5                          $5~ 
E Opinion(optional) 
 
 
 
